| 3.6 |
3.6 |
GO:0061113 |
pancreas morphogenesis(GO:0061113) |
| 3.1 |
9.2 |
GO:0048352 |
neural plate mediolateral regionalization(GO:0021998) mesoderm structural organization(GO:0048338) paraxial mesoderm structural organization(GO:0048352) |
| 2.9 |
8.8 |
GO:0014028 |
notochord formation(GO:0014028) |
| 2.9 |
11.7 |
GO:2001032 |
regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
| 2.9 |
11.4 |
GO:0018242 |
protein O-linked glycosylation via serine(GO:0018242) |
| 2.8 |
8.3 |
GO:0060853 |
arterial endothelial cell fate commitment(GO:0060844) blood vessel endothelial cell fate commitment(GO:0060846) endothelial cell fate specification(GO:0060847) Notch signaling pathway involved in arterial endothelial cell fate commitment(GO:0060853) blood vessel endothelial cell fate specification(GO:0097101) |
| 2.6 |
7.8 |
GO:0060364 |
frontal suture morphogenesis(GO:0060364) |
| 2.4 |
4.8 |
GO:2000977 |
regulation of forebrain neuron differentiation(GO:2000977) |
| 2.3 |
11.6 |
GO:0070345 |
negative regulation of fat cell proliferation(GO:0070345) |
| 2.3 |
11.6 |
GO:0021905 |
pancreatic A cell development(GO:0003322) forebrain-midbrain boundary formation(GO:0021905) somatic motor neuron fate commitment(GO:0021917) regulation of transcription from RNA polymerase II promoter involved in somatic motor neuron fate commitment(GO:0021918) |
| 2.3 |
11.3 |
GO:0007089 |
traversing start control point of mitotic cell cycle(GO:0007089) |
| 2.2 |
4.3 |
GO:0072180 |
mesonephric duct development(GO:0072177) mesonephric duct morphogenesis(GO:0072180) |
| 2.1 |
2.1 |
GO:0016332 |
establishment or maintenance of polarity of embryonic epithelium(GO:0016332) |
| 2.0 |
6.0 |
GO:0048496 |
maintenance of organ identity(GO:0048496) |
| 2.0 |
2.0 |
GO:0042660 |
positive regulation of cell fate specification(GO:0042660) |
| 1.9 |
5.8 |
GO:0006546 |
glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 1.9 |
5.7 |
GO:1904059 |
regulation of locomotor rhythm(GO:1904059) |
| 1.9 |
9.5 |
GO:0071394 |
cellular response to testosterone stimulus(GO:0071394) |
| 1.9 |
5.6 |
GO:0060994 |
regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
| 1.9 |
5.6 |
GO:0086069 |
bundle of His cell to Purkinje myocyte communication(GO:0086069) |
| 1.8 |
5.5 |
GO:0060217 |
hemangioblast cell differentiation(GO:0060217) |
| 1.8 |
7.2 |
GO:0070858 |
negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
| 1.8 |
5.3 |
GO:0090234 |
regulation of kinetochore assembly(GO:0090234) |
| 1.7 |
5.2 |
GO:0046671 |
negative regulation of retinal cell programmed cell death(GO:0046671) |
| 1.7 |
16.7 |
GO:0060272 |
embryonic skeletal joint morphogenesis(GO:0060272) |
| 1.6 |
6.4 |
GO:0046469 |
platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
| 1.6 |
3.2 |
GO:0046628 |
positive regulation of insulin receptor signaling pathway(GO:0046628) |
| 1.5 |
4.5 |
GO:0070844 |
misfolded protein transport(GO:0070843) polyubiquitinated protein transport(GO:0070844) polyubiquitinated misfolded protein transport(GO:0070845) Hsp90 deacetylation(GO:0070846) |
| 1.5 |
4.5 |
GO:1903998 |
regulation of eating behavior(GO:1903998) |
| 1.5 |
4.4 |
GO:0002842 |
T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) positive regulation of T cell mediated immune response to tumor cell(GO:0002842) |
| 1.5 |
13.3 |
GO:0046499 |
S-adenosylmethioninamine metabolic process(GO:0046499) |
| 1.5 |
4.4 |
GO:2000616 |
negative regulation of histone H3-K9 acetylation(GO:2000616) |
| 1.5 |
1.5 |
GO:0045976 |
negative regulation of mitotic cell cycle, embryonic(GO:0045976) |
| 1.5 |
5.8 |
GO:0000255 |
allantoin metabolic process(GO:0000255) |
| 1.5 |
4.4 |
GO:0060598 |
dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis(GO:0060598) |
| 1.4 |
5.6 |
GO:0046655 |
folic acid metabolic process(GO:0046655) |
| 1.4 |
5.6 |
GO:0003199 |
endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
| 1.4 |
1.4 |
GO:0072048 |
pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) |
| 1.4 |
5.5 |
GO:0003360 |
brainstem development(GO:0003360) |
| 1.4 |
1.4 |
GO:0033122 |
regulation of purine nucleotide catabolic process(GO:0033121) negative regulation of purine nucleotide catabolic process(GO:0033122) |
| 1.3 |
4.0 |
GO:0032916 |
transforming growth factor beta3 production(GO:0032907) regulation of transforming growth factor beta3 production(GO:0032910) positive regulation of transforming growth factor beta3 production(GO:0032916) |
| 1.3 |
2.6 |
GO:0051295 |
establishment of meiotic spindle localization(GO:0051295) |
| 1.3 |
2.6 |
GO:0060838 |
lymphatic endothelial cell fate commitment(GO:0060838) regulation of transcription involved in lymphatic endothelial cell fate commitment(GO:0060849) |
| 1.3 |
1.3 |
GO:0009786 |
regulation of asymmetric cell division(GO:0009786) |
| 1.3 |
3.8 |
GO:0045819 |
positive regulation of glycogen catabolic process(GO:0045819) |
| 1.3 |
10.0 |
GO:0033314 |
mitotic DNA replication checkpoint(GO:0033314) |
| 1.2 |
6.2 |
GO:0006447 |
regulation of translational initiation by iron(GO:0006447) positive regulation of translational initiation by iron(GO:0045994) |
| 1.2 |
3.7 |
GO:1900275 |
negative regulation of phospholipase C activity(GO:1900275) |
| 1.2 |
8.7 |
GO:0072257 |
metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
| 1.2 |
3.7 |
GO:0007223 |
Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
| 1.2 |
9.8 |
GO:0048852 |
diencephalon morphogenesis(GO:0048852) |
| 1.2 |
2.4 |
GO:0021913 |
regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
| 1.2 |
1.2 |
GO:0061324 |
canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation(GO:0061324) planar cell polarity pathway involved in outflow tract morphogenesis(GO:0061347) planar cell polarity pathway involved in ventricular septum morphogenesis(GO:0061348) planar cell polarity pathway involved in cardiac right atrium morphogenesis(GO:0061349) planar cell polarity pathway involved in cardiac muscle tissue morphogenesis(GO:0061350) planar cell polarity pathway involved in pericardium morphogenesis(GO:0061354) regulation of cell proliferation involved in outflow tract morphogenesis(GO:1901963) |
| 1.2 |
3.6 |
GO:0032474 |
otolith morphogenesis(GO:0032474) |
| 1.2 |
6.0 |
GO:2000065 |
negative regulation of aldosterone metabolic process(GO:0032345) negative regulation of aldosterone biosynthetic process(GO:0032348) negative regulation of cortisol biosynthetic process(GO:2000065) |
| 1.2 |
3.6 |
GO:0021759 |
globus pallidus development(GO:0021759) |
| 1.2 |
4.7 |
GO:0035606 |
peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
| 1.2 |
3.5 |
GO:0030421 |
defecation(GO:0030421) |
| 1.1 |
3.4 |
GO:0018298 |
protein-chromophore linkage(GO:0018298) |
| 1.1 |
3.4 |
GO:0071680 |
response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
| 1.1 |
3.4 |
GO:0016078 |
tRNA catabolic process(GO:0016078) |
| 1.1 |
3.4 |
GO:0033566 |
gamma-tubulin complex localization(GO:0033566) |
| 1.1 |
1.1 |
GO:0061198 |
fungiform papilla formation(GO:0061198) |
| 1.1 |
6.6 |
GO:1903755 |
regulation of SUMO transferase activity(GO:1903182) positive regulation of SUMO transferase activity(GO:1903755) |
| 1.1 |
4.4 |
GO:0070829 |
heterochromatin maintenance(GO:0070829) |
| 1.1 |
7.6 |
GO:1904667 |
negative regulation of ubiquitin protein ligase activity(GO:1904667) |
| 1.1 |
3.2 |
GO:0050929 |
corticospinal neuron axon guidance through spinal cord(GO:0021972) positive regulation of negative chemotaxis(GO:0050924) induction of negative chemotaxis(GO:0050929) negative regulation of mononuclear cell migration(GO:0071676) negative regulation of retinal ganglion cell axon guidance(GO:0090260) |
| 1.1 |
1.1 |
GO:0060741 |
prostate gland stromal morphogenesis(GO:0060741) |
| 1.1 |
3.2 |
GO:0007161 |
calcium-independent cell-matrix adhesion(GO:0007161) |
| 1.1 |
3.2 |
GO:1904395 |
regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904393) positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) |
| 1.1 |
3.2 |
GO:0061642 |
chemoattraction of axon(GO:0061642) |
| 1.1 |
8.4 |
GO:0060059 |
embryonic retina morphogenesis in camera-type eye(GO:0060059) |
| 1.0 |
5.2 |
GO:1902570 |
protein localization to nucleolus(GO:1902570) |
| 1.0 |
1.0 |
GO:1904357 |
negative regulation of telomere maintenance via telomere lengthening(GO:1904357) |
| 1.0 |
4.1 |
GO:1903011 |
negative regulation of bone development(GO:1903011) |
| 1.0 |
17.5 |
GO:0021516 |
dorsal spinal cord development(GO:0021516) |
| 1.0 |
5.1 |
GO:0070934 |
CRD-mediated mRNA stabilization(GO:0070934) |
| 1.0 |
1.0 |
GO:0032286 |
central nervous system myelin maintenance(GO:0032286) |
| 1.0 |
3.0 |
GO:1903048 |
regulation of acetylcholine-gated cation channel activity(GO:1903048) |
| 1.0 |
2.0 |
GO:0009177 |
deoxyribonucleoside monophosphate biosynthetic process(GO:0009157) pyrimidine deoxyribonucleoside monophosphate biosynthetic process(GO:0009177) |
| 1.0 |
1.0 |
GO:0072204 |
cell-cell signaling involved in kidney development(GO:0060995) Wnt signaling pathway involved in kidney development(GO:0061289) canonical Wnt signaling pathway involved in metanephric kidney development(GO:0061290) cell-cell signaling involved in metanephros development(GO:0072204) |
| 1.0 |
1.0 |
GO:2000832 |
negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
| 1.0 |
5.9 |
GO:0016540 |
protein autoprocessing(GO:0016540) |
| 1.0 |
5.9 |
GO:0033567 |
DNA replication, Okazaki fragment processing(GO:0033567) |
| 1.0 |
7.8 |
GO:0051574 |
positive regulation of histone H3-K9 methylation(GO:0051574) |
| 1.0 |
3.9 |
GO:1900145 |
regulation of nodal signaling pathway involved in determination of left/right asymmetry(GO:1900145) regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900175) positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) positive regulation of mesoderm development(GO:2000382) |
| 1.0 |
5.8 |
GO:0060017 |
parathyroid gland development(GO:0060017) |
| 1.0 |
3.9 |
GO:0000733 |
DNA strand renaturation(GO:0000733) |
| 1.0 |
3.9 |
GO:0014816 |
skeletal muscle satellite cell differentiation(GO:0014816) |
| 1.0 |
2.9 |
GO:0042998 |
positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
| 1.0 |
2.9 |
GO:0021698 |
cerebellar cortex structural organization(GO:0021698) |
| 1.0 |
8.6 |
GO:0045719 |
negative regulation of glycogen biosynthetic process(GO:0045719) negative regulation of glycogen metabolic process(GO:0070874) |
| 1.0 |
2.9 |
GO:0006083 |
acetate metabolic process(GO:0006083) |
| 1.0 |
5.7 |
GO:0085020 |
protein K6-linked ubiquitination(GO:0085020) |
| 0.9 |
5.6 |
GO:0035087 |
siRNA loading onto RISC involved in RNA interference(GO:0035087) |
| 0.9 |
2.8 |
GO:0019659 |
glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
| 0.9 |
1.9 |
GO:0046370 |
fructose biosynthetic process(GO:0046370) |
| 0.9 |
1.9 |
GO:0051387 |
negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
| 0.9 |
0.9 |
GO:0060821 |
inactivation of X chromosome by DNA methylation(GO:0060821) |
| 0.9 |
3.7 |
GO:0071047 |
nuclear polyadenylation-dependent mRNA catabolic process(GO:0071042) polyadenylation-dependent mRNA catabolic process(GO:0071047) |
| 0.9 |
2.7 |
GO:0006059 |
hexitol metabolic process(GO:0006059) |
| 0.9 |
0.9 |
GO:0051984 |
positive regulation of chromosome segregation(GO:0051984) |
| 0.9 |
3.6 |
GO:0034184 |
positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
| 0.9 |
4.5 |
GO:0010032 |
meiotic chromosome condensation(GO:0010032) |
| 0.9 |
3.6 |
GO:0031052 |
programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
| 0.9 |
1.8 |
GO:0000715 |
nucleotide-excision repair, DNA damage recognition(GO:0000715) |
| 0.9 |
2.7 |
GO:2000686 |
regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
| 0.9 |
1.8 |
GO:0021557 |
oculomotor nerve development(GO:0021557) |
| 0.9 |
0.9 |
GO:0060399 |
positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
| 0.9 |
2.7 |
GO:0003349 |
epicardium-derived cardiac endothelial cell differentiation(GO:0003349) |
| 0.9 |
2.7 |
GO:0021849 |
neuroblast division in subventricular zone(GO:0021849) |
| 0.9 |
1.8 |
GO:2000048 |
negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
| 0.9 |
2.6 |
GO:0003221 |
right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
| 0.9 |
3.5 |
GO:0051866 |
general adaptation syndrome(GO:0051866) |
| 0.9 |
1.8 |
GO:0036518 |
chemorepulsion of dopaminergic neuron axon(GO:0036518) |
| 0.9 |
4.4 |
GO:0000076 |
DNA replication checkpoint(GO:0000076) |
| 0.9 |
5.2 |
GO:0038031 |
non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
| 0.9 |
2.6 |
GO:0007084 |
mitotic nuclear envelope reassembly(GO:0007084) |
| 0.9 |
4.3 |
GO:1904690 |
regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
| 0.9 |
4.3 |
GO:0015867 |
ATP transport(GO:0015867) |
| 0.9 |
8.5 |
GO:1902459 |
positive regulation of stem cell population maintenance(GO:1902459) |
| 0.8 |
2.5 |
GO:0070602 |
regulation of centromeric sister chromatid cohesion(GO:0070602) |
| 0.8 |
0.8 |
GO:0090024 |
negative regulation of granulocyte chemotaxis(GO:0071623) negative regulation of neutrophil chemotaxis(GO:0090024) negative regulation of neutrophil migration(GO:1902623) |
| 0.8 |
2.5 |
GO:0003162 |
atrioventricular node development(GO:0003162) |
| 0.8 |
0.8 |
GO:0061484 |
hematopoietic stem cell homeostasis(GO:0061484) |
| 0.8 |
2.5 |
GO:1901675 |
response to methylglyoxal(GO:0051595) negative regulation of histone H3-K27 acetylation(GO:1901675) |
| 0.8 |
6.6 |
GO:0032525 |
somite rostral/caudal axis specification(GO:0032525) |
| 0.8 |
3.3 |
GO:0046061 |
dATP catabolic process(GO:0046061) |
| 0.8 |
4.9 |
GO:2000781 |
positive regulation of double-strand break repair(GO:2000781) |
| 0.8 |
2.5 |
GO:0000710 |
meiotic mismatch repair(GO:0000710) |
| 0.8 |
5.7 |
GO:0000022 |
mitotic spindle elongation(GO:0000022) mitotic spindle midzone assembly(GO:0051256) |
| 0.8 |
5.7 |
GO:0030903 |
notochord development(GO:0030903) |
| 0.8 |
2.4 |
GO:0035878 |
nail development(GO:0035878) |
| 0.8 |
2.4 |
GO:0071649 |
regulation of chemokine (C-C motif) ligand 5 production(GO:0071649) |
| 0.8 |
3.2 |
GO:0046836 |
glycolipid transport(GO:0046836) |
| 0.8 |
4.8 |
GO:0006177 |
GMP biosynthetic process(GO:0006177) |
| 0.8 |
2.4 |
GO:0044339 |
canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
| 0.8 |
2.4 |
GO:2000195 |
negative regulation of female gonad development(GO:2000195) |
| 0.8 |
8.8 |
GO:0046643 |
regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
| 0.8 |
7.2 |
GO:0021521 |
ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
| 0.8 |
2.4 |
GO:0002184 |
cytoplasmic translational termination(GO:0002184) |
| 0.8 |
3.2 |
GO:0046654 |
tetrahydrofolate biosynthetic process(GO:0046654) |
| 0.8 |
1.6 |
GO:0046122 |
purine deoxyribonucleoside metabolic process(GO:0046122) |
| 0.8 |
3.9 |
GO:0030091 |
protein repair(GO:0030091) |
| 0.8 |
2.3 |
GO:0003190 |
atrioventricular valve formation(GO:0003190) |
| 0.8 |
10.8 |
GO:0051292 |
nuclear pore complex assembly(GO:0051292) |
| 0.8 |
2.3 |
GO:0019255 |
glucose 1-phosphate metabolic process(GO:0019255) |
| 0.8 |
1.5 |
GO:0003415 |
chondrocyte hypertrophy(GO:0003415) |
| 0.8 |
2.3 |
GO:0002408 |
myeloid dendritic cell chemotaxis(GO:0002408) |
| 0.8 |
4.6 |
GO:0045583 |
regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
| 0.8 |
2.3 |
GO:0007354 |
zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
| 0.7 |
2.2 |
GO:1903334 |
positive regulation of protein folding(GO:1903334) |
| 0.7 |
4.5 |
GO:0036089 |
cleavage furrow formation(GO:0036089) |
| 0.7 |
2.2 |
GO:0006578 |
amino-acid betaine biosynthetic process(GO:0006578) |
| 0.7 |
4.4 |
GO:0021747 |
cochlear nucleus development(GO:0021747) |
| 0.7 |
2.2 |
GO:0033860 |
regulation of NAD(P)H oxidase activity(GO:0033860) |
| 0.7 |
2.9 |
GO:0072383 |
plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
| 0.7 |
2.2 |
GO:1903225 |
negative regulation of endodermal cell differentiation(GO:1903225) |
| 0.7 |
2.1 |
GO:0006106 |
fumarate metabolic process(GO:0006106) |
| 0.7 |
2.1 |
GO:0010814 |
substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
| 0.7 |
2.1 |
GO:0014005 |
microglia differentiation(GO:0014004) microglia development(GO:0014005) |
| 0.7 |
0.7 |
GO:0060455 |
regulation of gastric acid secretion(GO:0060453) negative regulation of gastric acid secretion(GO:0060455) |
| 0.7 |
4.9 |
GO:0001842 |
neural fold formation(GO:0001842) |
| 0.7 |
4.2 |
GO:0046985 |
positive regulation of hemoglobin biosynthetic process(GO:0046985) |
| 0.7 |
7.0 |
GO:0090557 |
establishment of endothelial intestinal barrier(GO:0090557) |
| 0.7 |
4.9 |
GO:0043353 |
enucleate erythrocyte differentiation(GO:0043353) |
| 0.7 |
5.5 |
GO:0008063 |
Toll signaling pathway(GO:0008063) |
| 0.7 |
9.7 |
GO:0071459 |
protein localization to chromosome, centromeric region(GO:0071459) |
| 0.7 |
3.4 |
GO:1904948 |
midbrain dopaminergic neuron differentiation(GO:1904948) |
| 0.7 |
10.3 |
GO:0035563 |
positive regulation of chromatin binding(GO:0035563) |
| 0.7 |
1.4 |
GO:0030997 |
regulation of centriole-centriole cohesion(GO:0030997) |
| 0.7 |
2.7 |
GO:0045578 |
negative regulation of B cell differentiation(GO:0045578) |
| 0.7 |
1.4 |
GO:0007290 |
spermatid nucleus elongation(GO:0007290) |
| 0.7 |
2.7 |
GO:0010510 |
regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
| 0.7 |
2.0 |
GO:1904154 |
positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
| 0.7 |
2.0 |
GO:2000271 |
positive regulation of fibroblast apoptotic process(GO:2000271) |
| 0.7 |
2.0 |
GO:0045738 |
negative regulation of DNA repair(GO:0045738) |
| 0.7 |
1.3 |
GO:2000744 |
anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
| 0.7 |
4.7 |
GO:0016446 |
somatic hypermutation of immunoglobulin genes(GO:0016446) |
| 0.7 |
2.0 |
GO:0001880 |
Mullerian duct regression(GO:0001880) |
| 0.7 |
2.0 |
GO:0060558 |
regulation of calcidiol 1-monooxygenase activity(GO:0060558) |
| 0.7 |
3.3 |
GO:0016127 |
cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
| 0.7 |
2.0 |
GO:0090526 |
regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
| 0.6 |
3.2 |
GO:0021797 |
forebrain anterior/posterior pattern specification(GO:0021797) |
| 0.6 |
2.6 |
GO:1904565 |
response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
| 0.6 |
5.1 |
GO:0043046 |
DNA methylation involved in gamete generation(GO:0043046) |
| 0.6 |
8.3 |
GO:0030948 |
negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
| 0.6 |
8.3 |
GO:0021978 |
telencephalon regionalization(GO:0021978) |
| 0.6 |
2.5 |
GO:0035262 |
gonad morphogenesis(GO:0035262) |
| 0.6 |
0.6 |
GO:0050883 |
musculoskeletal movement, spinal reflex action(GO:0050883) |
| 0.6 |
2.5 |
GO:0015705 |
iodide transport(GO:0015705) |
| 0.6 |
1.9 |
GO:1900041 |
negative regulation of interleukin-2 secretion(GO:1900041) |
| 0.6 |
2.5 |
GO:0033326 |
cerebrospinal fluid secretion(GO:0033326) |
| 0.6 |
2.5 |
GO:0016266 |
O-glycan processing(GO:0016266) |
| 0.6 |
0.6 |
GO:0071478 |
cellular response to radiation(GO:0071478) |
| 0.6 |
0.6 |
GO:0010804 |
negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
| 0.6 |
13.0 |
GO:0006607 |
NLS-bearing protein import into nucleus(GO:0006607) |
| 0.6 |
4.9 |
GO:0000395 |
mRNA 5'-splice site recognition(GO:0000395) |
| 0.6 |
3.7 |
GO:0006344 |
maintenance of chromatin silencing(GO:0006344) |
| 0.6 |
1.2 |
GO:0034433 |
steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
| 0.6 |
0.6 |
GO:1903519 |
apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
| 0.6 |
0.6 |
GO:0046036 |
CTP biosynthetic process(GO:0006241) CTP metabolic process(GO:0046036) |
| 0.6 |
2.4 |
GO:0035188 |
blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
| 0.6 |
9.0 |
GO:0000183 |
chromatin silencing at rDNA(GO:0000183) |
| 0.6 |
4.2 |
GO:0007440 |
foregut morphogenesis(GO:0007440) |
| 0.6 |
1.2 |
GO:0010519 |
negative regulation of phospholipase activity(GO:0010519) |
| 0.6 |
3.0 |
GO:0060754 |
positive regulation of mast cell chemotaxis(GO:0060754) |
| 0.6 |
1.2 |
GO:0060528 |
secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
| 0.6 |
1.2 |
GO:0018171 |
peptidyl-cysteine oxidation(GO:0018171) |
| 0.6 |
1.8 |
GO:0006271 |
DNA strand elongation involved in DNA replication(GO:0006271) |
| 0.6 |
1.8 |
GO:1904274 |
tricellular tight junction assembly(GO:1904274) |
| 0.6 |
3.0 |
GO:0035331 |
negative regulation of hippo signaling(GO:0035331) |
| 0.6 |
0.6 |
GO:0003245 |
cardiac muscle tissue growth involved in heart morphogenesis(GO:0003245) |
| 0.6 |
1.2 |
GO:0090274 |
positive regulation of somatostatin secretion(GO:0090274) |
| 0.6 |
1.2 |
GO:0045776 |
negative regulation of blood pressure(GO:0045776) |
| 0.6 |
1.8 |
GO:0001732 |
formation of cytoplasmic translation initiation complex(GO:0001732) |
| 0.6 |
1.2 |
GO:0036091 |
positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
| 0.6 |
0.6 |
GO:0030225 |
macrophage differentiation(GO:0030225) |
| 0.6 |
1.2 |
GO:1901420 |
negative regulation of response to alcohol(GO:1901420) |
| 0.6 |
2.9 |
GO:0006369 |
termination of RNA polymerase II transcription(GO:0006369) |
| 0.6 |
1.7 |
GO:0032053 |
ciliary basal body organization(GO:0032053) |
| 0.6 |
5.2 |
GO:0010216 |
maintenance of DNA methylation(GO:0010216) |
| 0.6 |
1.2 |
GO:1990414 |
cellular response to camptothecin(GO:0072757) replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
| 0.6 |
0.6 |
GO:0006933 |
negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
| 0.6 |
1.2 |
GO:1990705 |
cholangiocyte proliferation(GO:1990705) |
| 0.6 |
5.2 |
GO:0051639 |
actin filament network formation(GO:0051639) |
| 0.6 |
1.7 |
GO:0031590 |
wybutosine metabolic process(GO:0031590) wybutosine biosynthetic process(GO:0031591) |
| 0.6 |
0.6 |
GO:0060535 |
trachea cartilage morphogenesis(GO:0060535) |
| 0.6 |
1.7 |
GO:1902498 |
regulation of protein autoubiquitination(GO:1902498) |
| 0.6 |
1.1 |
GO:0003306 |
Wnt signaling pathway involved in heart development(GO:0003306) |
| 0.6 |
3.4 |
GO:0006999 |
nuclear pore organization(GO:0006999) |
| 0.6 |
0.6 |
GO:1903251 |
multi-ciliated epithelial cell differentiation(GO:1903251) |
| 0.6 |
1.7 |
GO:0032058 |
positive regulation of translational initiation in response to stress(GO:0032058) |
| 0.6 |
5.6 |
GO:0006085 |
acetyl-CoA biosynthetic process(GO:0006085) |
| 0.6 |
1.7 |
GO:0036092 |
phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
| 0.6 |
3.9 |
GO:0000103 |
sulfate assimilation(GO:0000103) |
| 0.6 |
1.7 |
GO:0042505 |
tyrosine phosphorylation of Stat6 protein(GO:0042505) regulation of tyrosine phosphorylation of Stat6 protein(GO:0042525) |
| 0.6 |
1.7 |
GO:0090071 |
negative regulation of ribosome biogenesis(GO:0090071) |
| 0.6 |
1.7 |
GO:0006166 |
purine ribonucleoside salvage(GO:0006166) |
| 0.6 |
1.1 |
GO:0018076 |
N-terminal peptidyl-lysine acetylation(GO:0018076) |
| 0.6 |
3.9 |
GO:0001736 |
establishment of planar polarity(GO:0001736) establishment of tissue polarity(GO:0007164) |
| 0.6 |
3.3 |
GO:0010457 |
centriole-centriole cohesion(GO:0010457) |
| 0.5 |
4.9 |
GO:0098535 |
de novo centriole assembly(GO:0098535) |
| 0.5 |
7.1 |
GO:0010569 |
regulation of double-strand break repair via homologous recombination(GO:0010569) |
| 0.5 |
1.6 |
GO:0032493 |
response to bacterial lipoprotein(GO:0032493) |
| 0.5 |
2.2 |
GO:0048853 |
forebrain morphogenesis(GO:0048853) |
| 0.5 |
0.5 |
GO:0034661 |
ncRNA catabolic process(GO:0034661) |
| 0.5 |
1.6 |
GO:0009174 |
UMP biosynthetic process(GO:0006222) pyrimidine nucleoside monophosphate biosynthetic process(GO:0009130) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
| 0.5 |
2.2 |
GO:1901165 |
positive regulation of trophoblast cell migration(GO:1901165) |
| 0.5 |
3.2 |
GO:0006105 |
succinate metabolic process(GO:0006105) |
| 0.5 |
1.1 |
GO:0061525 |
hindgut morphogenesis(GO:0007442) embryonic genitalia morphogenesis(GO:0030538) embryonic hindgut morphogenesis(GO:0048619) hindgut development(GO:0061525) |
| 0.5 |
3.2 |
GO:0003383 |
apical constriction(GO:0003383) |
| 0.5 |
0.5 |
GO:0060066 |
oviduct development(GO:0060066) |
| 0.5 |
4.2 |
GO:0030261 |
chromosome condensation(GO:0030261) |
| 0.5 |
0.5 |
GO:0001738 |
morphogenesis of a polarized epithelium(GO:0001738) |
| 0.5 |
16.4 |
GO:0006270 |
DNA replication initiation(GO:0006270) |
| 0.5 |
1.1 |
GO:1904380 |
endoplasmic reticulum mannose trimming(GO:1904380) |
| 0.5 |
0.5 |
GO:0035616 |
histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
| 0.5 |
2.1 |
GO:2000774 |
positive regulation of cellular senescence(GO:2000774) |
| 0.5 |
13.1 |
GO:0045880 |
positive regulation of smoothened signaling pathway(GO:0045880) |
| 0.5 |
2.1 |
GO:0048304 |
positive regulation of isotype switching to IgG isotypes(GO:0048304) |
| 0.5 |
2.1 |
GO:2000324 |
positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
| 0.5 |
1.5 |
GO:0043586 |
tongue development(GO:0043586) |
| 0.5 |
2.6 |
GO:0003420 |
regulation of growth plate cartilage chondrocyte proliferation(GO:0003420) |
| 0.5 |
17.9 |
GO:0006284 |
base-excision repair(GO:0006284) |
| 0.5 |
5.1 |
GO:0033234 |
negative regulation of protein sumoylation(GO:0033234) |
| 0.5 |
1.5 |
GO:0030210 |
heparin biosynthetic process(GO:0030210) |
| 0.5 |
0.5 |
GO:0071218 |
cellular response to misfolded protein(GO:0071218) |
| 0.5 |
1.0 |
GO:2000418 |
positive regulation of eosinophil migration(GO:2000418) |
| 0.5 |
1.0 |
GO:0018158 |
protein oxidation(GO:0018158) |
| 0.5 |
2.0 |
GO:0016259 |
selenocysteine metabolic process(GO:0016259) |
| 0.5 |
4.0 |
GO:1902231 |
positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
| 0.5 |
2.0 |
GO:0051643 |
endoplasmic reticulum localization(GO:0051643) |
| 0.5 |
5.0 |
GO:0043568 |
positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
| 0.5 |
4.5 |
GO:0010606 |
positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
| 0.5 |
2.0 |
GO:2000051 |
negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
| 0.5 |
2.0 |
GO:0014846 |
esophagus smooth muscle contraction(GO:0014846) glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
| 0.5 |
1.0 |
GO:0060011 |
Sertoli cell proliferation(GO:0060011) |
| 0.5 |
4.5 |
GO:0000083 |
regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
| 0.5 |
3.0 |
GO:0034260 |
negative regulation of GTPase activity(GO:0034260) |
| 0.5 |
2.0 |
GO:0007113 |
endomitotic cell cycle(GO:0007113) |
| 0.5 |
1.5 |
GO:0032463 |
negative regulation of protein homooligomerization(GO:0032463) |
| 0.5 |
1.9 |
GO:0019355 |
nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
| 0.5 |
1.0 |
GO:0006931 |
substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 0.5 |
3.9 |
GO:1990403 |
embryonic brain development(GO:1990403) |
| 0.5 |
1.5 |
GO:0072202 |
cell differentiation involved in metanephros development(GO:0072202) |
| 0.5 |
5.3 |
GO:0006000 |
fructose metabolic process(GO:0006000) |
| 0.5 |
4.8 |
GO:0044872 |
lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
| 0.5 |
1.0 |
GO:0031124 |
mRNA 3'-end processing(GO:0031124) |
| 0.5 |
3.8 |
GO:0008343 |
adult feeding behavior(GO:0008343) |
| 0.5 |
2.9 |
GO:0043922 |
negative regulation by host of viral transcription(GO:0043922) |
| 0.5 |
1.9 |
GO:0070425 |
regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070424) negative regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070425) regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070432) negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070433) |
| 0.5 |
1.4 |
GO:0048696 |
regulation of collateral sprouting in absence of injury(GO:0048696) |
| 0.5 |
2.8 |
GO:0090399 |
replicative senescence(GO:0090399) |
| 0.5 |
4.2 |
GO:0006337 |
nucleosome disassembly(GO:0006337) protein-DNA complex disassembly(GO:0032986) |
| 0.5 |
0.9 |
GO:0010838 |
positive regulation of keratinocyte proliferation(GO:0010838) |
| 0.5 |
2.3 |
GO:0097501 |
stress response to metal ion(GO:0097501) |
| 0.5 |
2.3 |
GO:0032472 |
Golgi calcium ion transport(GO:0032472) |
| 0.5 |
1.9 |
GO:0042360 |
vitamin E metabolic process(GO:0042360) |
| 0.5 |
0.9 |
GO:0051304 |
chromosome separation(GO:0051304) |
| 0.5 |
4.7 |
GO:0045899 |
positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
| 0.5 |
3.3 |
GO:0016576 |
histone dephosphorylation(GO:0016576) |
| 0.5 |
0.9 |
GO:0060916 |
mesenchymal cell proliferation involved in lung development(GO:0060916) regulation of mesenchymal cell proliferation involved in lung development(GO:2000790) negative regulation of mesenchymal cell proliferation involved in lung development(GO:2000791) |
| 0.5 |
3.3 |
GO:0031936 |
negative regulation of chromatin silencing(GO:0031936) |
| 0.5 |
5.1 |
GO:2000675 |
negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
| 0.5 |
4.7 |
GO:0010452 |
histone H3-K36 methylation(GO:0010452) |
| 0.5 |
3.3 |
GO:0048096 |
chromatin-mediated maintenance of transcription(GO:0048096) |
| 0.5 |
1.4 |
GO:0001828 |
inner cell mass cell fate commitment(GO:0001827) inner cell mass cellular morphogenesis(GO:0001828) |
| 0.5 |
6.5 |
GO:2000353 |
positive regulation of endothelial cell apoptotic process(GO:2000353) |
| 0.5 |
0.5 |
GO:0035519 |
protein K29-linked ubiquitination(GO:0035519) |
| 0.5 |
7.9 |
GO:0071539 |
protein localization to centrosome(GO:0071539) |
| 0.5 |
0.9 |
GO:0032760 |
positive regulation of tumor necrosis factor production(GO:0032760) positive regulation of tumor necrosis factor superfamily cytokine production(GO:1903557) |
| 0.5 |
0.5 |
GO:0030916 |
otic vesicle formation(GO:0030916) |
| 0.5 |
1.8 |
GO:0046602 |
regulation of mitotic centrosome separation(GO:0046602) |
| 0.5 |
5.1 |
GO:0000578 |
embryonic axis specification(GO:0000578) |
| 0.5 |
2.3 |
GO:0002315 |
marginal zone B cell differentiation(GO:0002315) |
| 0.5 |
0.5 |
GO:0032747 |
positive regulation of interleukin-23 production(GO:0032747) |
| 0.5 |
3.2 |
GO:0061032 |
visceral serous pericardium development(GO:0061032) |
| 0.5 |
0.5 |
GO:2000298 |
regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
| 0.5 |
1.4 |
GO:0060215 |
primitive hemopoiesis(GO:0060215) |
| 0.5 |
1.4 |
GO:0097461 |
ferric iron import(GO:0033216) ferric iron import into cell(GO:0097461) |
| 0.5 |
1.8 |
GO:0003365 |
establishment of cell polarity involved in ameboidal cell migration(GO:0003365) |
| 0.5 |
1.4 |
GO:0006597 |
spermine biosynthetic process(GO:0006597) |
| 0.5 |
1.4 |
GO:0045472 |
response to ether(GO:0045472) |
| 0.5 |
2.3 |
GO:0001711 |
endodermal cell fate commitment(GO:0001711) |
| 0.5 |
6.8 |
GO:0048387 |
negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
| 0.4 |
1.8 |
GO:0008635 |
activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
| 0.4 |
4.9 |
GO:0040037 |
negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
| 0.4 |
3.6 |
GO:0033182 |
regulation of histone ubiquitination(GO:0033182) |
| 0.4 |
8.9 |
GO:0007140 |
male meiosis(GO:0007140) |
| 0.4 |
1.8 |
GO:0042414 |
epinephrine metabolic process(GO:0042414) |
| 0.4 |
1.8 |
GO:0015888 |
thiamine transport(GO:0015888) |
| 0.4 |
0.4 |
GO:0031339 |
negative regulation of vesicle fusion(GO:0031339) |
| 0.4 |
0.4 |
GO:0035845 |
photoreceptor cell outer segment organization(GO:0035845) |
| 0.4 |
2.2 |
GO:0014886 |
transition between slow and fast fiber(GO:0014886) |
| 0.4 |
1.3 |
GO:0036353 |
histone H2A-K119 monoubiquitination(GO:0036353) |
| 0.4 |
1.3 |
GO:0072718 |
response to cisplatin(GO:0072718) |
| 0.4 |
6.6 |
GO:0050434 |
positive regulation of viral transcription(GO:0050434) |
| 0.4 |
7.5 |
GO:1902857 |
positive regulation of nonmotile primary cilium assembly(GO:1902857) |
| 0.4 |
2.2 |
GO:0034421 |
post-translational protein acetylation(GO:0034421) |
| 0.4 |
0.4 |
GO:0042059 |
negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) negative regulation of ERBB signaling pathway(GO:1901185) |
| 0.4 |
0.9 |
GO:0034393 |
positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
| 0.4 |
1.7 |
GO:0038128 |
ERBB2 signaling pathway(GO:0038128) |
| 0.4 |
0.4 |
GO:0030656 |
regulation of vitamin metabolic process(GO:0030656) |
| 0.4 |
4.8 |
GO:0046784 |
viral mRNA export from host cell nucleus(GO:0046784) |
| 0.4 |
3.0 |
GO:0031053 |
primary miRNA processing(GO:0031053) |
| 0.4 |
1.3 |
GO:0038203 |
TORC2 signaling(GO:0038203) |
| 0.4 |
1.7 |
GO:0061029 |
eyelid development in camera-type eye(GO:0061029) |
| 0.4 |
2.1 |
GO:0040032 |
post-embryonic body morphogenesis(GO:0040032) |
| 0.4 |
0.4 |
GO:1901563 |
response to camptothecin(GO:1901563) |
| 0.4 |
0.4 |
GO:0002070 |
epithelial cell maturation(GO:0002070) |
| 0.4 |
1.7 |
GO:0031581 |
hemidesmosome assembly(GO:0031581) |
| 0.4 |
5.1 |
GO:0051451 |
myoblast migration(GO:0051451) |
| 0.4 |
1.3 |
GO:0035426 |
extracellular matrix-cell signaling(GO:0035426) |
| 0.4 |
1.7 |
GO:1902410 |
mitotic cytokinetic process(GO:1902410) |
| 0.4 |
2.1 |
GO:0044351 |
macropinocytosis(GO:0044351) |
| 0.4 |
9.6 |
GO:0000303 |
response to superoxide(GO:0000303) |
| 0.4 |
1.7 |
GO:0072675 |
osteoclast fusion(GO:0072675) |
| 0.4 |
5.4 |
GO:0035329 |
hippo signaling(GO:0035329) |
| 0.4 |
2.1 |
GO:2000144 |
positive regulation of DNA-templated transcription, initiation(GO:2000144) |
| 0.4 |
1.2 |
GO:2001022 |
positive regulation of response to DNA damage stimulus(GO:2001022) |
| 0.4 |
6.1 |
GO:0038166 |
angiotensin-activated signaling pathway(GO:0038166) |
| 0.4 |
1.6 |
GO:0070537 |
histone H2A K63-linked deubiquitination(GO:0070537) |
| 0.4 |
0.4 |
GO:0033092 |
positive regulation of immature T cell proliferation in thymus(GO:0033092) |
| 0.4 |
3.3 |
GO:0060340 |
positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
| 0.4 |
2.0 |
GO:0006543 |
glutamine catabolic process(GO:0006543) |
| 0.4 |
4.0 |
GO:0070940 |
dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.4 |
0.8 |
GO:0019405 |
alditol catabolic process(GO:0019405) |
| 0.4 |
1.2 |
GO:2000834 |
androgen secretion(GO:0035935) testosterone secretion(GO:0035936) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) regulation of testosterone secretion(GO:2000843) positive regulation of testosterone secretion(GO:2000845) |
| 0.4 |
2.4 |
GO:0007296 |
vitellogenesis(GO:0007296) |
| 0.4 |
2.0 |
GO:0006346 |
methylation-dependent chromatin silencing(GO:0006346) |
| 0.4 |
1.6 |
GO:0042276 |
error-prone translesion synthesis(GO:0042276) |
| 0.4 |
0.8 |
GO:0038092 |
nodal signaling pathway(GO:0038092) |
| 0.4 |
1.6 |
GO:0046909 |
intermembrane transport(GO:0046909) |
| 0.4 |
1.9 |
GO:1903715 |
regulation of aerobic respiration(GO:1903715) |
| 0.4 |
0.8 |
GO:0048745 |
smooth muscle tissue development(GO:0048745) |
| 0.4 |
1.2 |
GO:0042822 |
vitamin B6 metabolic process(GO:0042816) pyridoxal phosphate metabolic process(GO:0042822) pyridoxal phosphate biosynthetic process(GO:0042823) |
| 0.4 |
1.9 |
GO:1903753 |
negative regulation of p38MAPK cascade(GO:1903753) |
| 0.4 |
0.4 |
GO:0006776 |
vitamin A metabolic process(GO:0006776) |
| 0.4 |
1.9 |
GO:2000301 |
negative regulation of synaptic vesicle exocytosis(GO:2000301) |
| 0.4 |
0.4 |
GO:0030202 |
heparin metabolic process(GO:0030202) |
| 0.4 |
4.6 |
GO:0060746 |
parental behavior(GO:0060746) |
| 0.4 |
1.9 |
GO:0007517 |
muscle organ development(GO:0007517) |
| 0.4 |
0.8 |
GO:0071896 |
protein localization to adherens junction(GO:0071896) |
| 0.4 |
1.1 |
GO:0009446 |
putrescine biosynthetic process(GO:0009446) |
| 0.4 |
0.8 |
GO:1902065 |
response to L-glutamate(GO:1902065) |
| 0.4 |
2.3 |
GO:0098734 |
protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
| 0.4 |
3.0 |
GO:0033145 |
positive regulation of intracellular steroid hormone receptor signaling pathway(GO:0033145) |
| 0.4 |
3.0 |
GO:0080111 |
DNA demethylation(GO:0080111) |
| 0.4 |
3.4 |
GO:0022027 |
interkinetic nuclear migration(GO:0022027) |
| 0.4 |
1.5 |
GO:1904491 |
protein localization to ciliary transition zone(GO:1904491) |
| 0.4 |
1.1 |
GO:0052428 |
modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
| 0.4 |
1.9 |
GO:0003283 |
atrial septum development(GO:0003283) |
| 0.4 |
0.7 |
GO:0000320 |
re-entry into mitotic cell cycle(GO:0000320) |
| 0.4 |
1.1 |
GO:0000350 |
generation of catalytic spliceosome for second transesterification step(GO:0000350) |
| 0.4 |
2.2 |
GO:0003433 |
chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
| 0.4 |
0.4 |
GO:0042713 |
sperm ejaculation(GO:0042713) |
| 0.4 |
0.7 |
GO:0036289 |
peptidyl-serine autophosphorylation(GO:0036289) |
| 0.4 |
2.9 |
GO:0045948 |
positive regulation of translational initiation(GO:0045948) |
| 0.4 |
0.7 |
GO:0002069 |
columnar/cuboidal epithelial cell maturation(GO:0002069) |
| 0.4 |
1.5 |
GO:1903265 |
positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 0.4 |
9.9 |
GO:0046039 |
GTP metabolic process(GO:0046039) |
| 0.4 |
0.7 |
GO:0060510 |
Type II pneumocyte differentiation(GO:0060510) |
| 0.4 |
0.4 |
GO:2001274 |
negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
| 0.4 |
2.6 |
GO:0051383 |
kinetochore organization(GO:0051383) |
| 0.4 |
1.1 |
GO:2000819 |
regulation of nucleotide-excision repair(GO:2000819) |
| 0.4 |
3.6 |
GO:0032211 |
negative regulation of telomere maintenance via telomerase(GO:0032211) |
| 0.4 |
0.7 |
GO:0002326 |
B cell lineage commitment(GO:0002326) |
| 0.4 |
1.1 |
GO:0048312 |
intracellular distribution of mitochondria(GO:0048312) |
| 0.4 |
2.2 |
GO:1900246 |
positive regulation of RIG-I signaling pathway(GO:1900246) |
| 0.4 |
0.4 |
GO:0072498 |
embryonic skeletal joint development(GO:0072498) |
| 0.4 |
1.1 |
GO:0006421 |
asparaginyl-tRNA aminoacylation(GO:0006421) |
| 0.4 |
0.7 |
GO:0030222 |
eosinophil differentiation(GO:0030222) |
| 0.4 |
0.4 |
GO:0035735 |
intraciliary transport involved in cilium morphogenesis(GO:0035735) |
| 0.4 |
3.2 |
GO:0070914 |
UV-damage excision repair(GO:0070914) |
| 0.4 |
2.8 |
GO:0006004 |
fucose metabolic process(GO:0006004) |
| 0.4 |
0.7 |
GO:0016340 |
calcium-dependent cell-matrix adhesion(GO:0016340) |
| 0.4 |
3.2 |
GO:0051307 |
meiotic chromosome separation(GO:0051307) |
| 0.3 |
5.9 |
GO:0043248 |
proteasome assembly(GO:0043248) |
| 0.3 |
4.5 |
GO:0000188 |
inactivation of MAPK activity(GO:0000188) |
| 0.3 |
1.4 |
GO:0032511 |
late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
| 0.3 |
0.7 |
GO:0015938 |
coenzyme A catabolic process(GO:0015938) nucleoside bisphosphate catabolic process(GO:0033869) ribonucleoside bisphosphate catabolic process(GO:0034031) purine nucleoside bisphosphate catabolic process(GO:0034034) |
| 0.3 |
0.7 |
GO:0060282 |
positive regulation of oocyte development(GO:0060282) |
| 0.3 |
2.7 |
GO:0034377 |
plasma lipoprotein particle assembly(GO:0034377) |
| 0.3 |
5.8 |
GO:0016180 |
snRNA processing(GO:0016180) |
| 0.3 |
0.3 |
GO:0030046 |
parallel actin filament bundle assembly(GO:0030046) |
| 0.3 |
1.4 |
GO:0043490 |
malate-aspartate shuttle(GO:0043490) |
| 0.3 |
1.0 |
GO:0097278 |
complement-dependent cytotoxicity(GO:0097278) |
| 0.3 |
2.3 |
GO:0070458 |
detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
| 0.3 |
0.7 |
GO:0019511 |
peptidyl-proline hydroxylation(GO:0019511) |
| 0.3 |
1.3 |
GO:0030576 |
Cajal body organization(GO:0030576) |
| 0.3 |
0.3 |
GO:0070670 |
response to interleukin-4(GO:0070670) |
| 0.3 |
1.7 |
GO:0090037 |
positive regulation of protein kinase C signaling(GO:0090037) |
| 0.3 |
0.7 |
GO:0032506 |
cytokinetic process(GO:0032506) |
| 0.3 |
1.7 |
GO:0046501 |
protoporphyrinogen IX metabolic process(GO:0046501) |
| 0.3 |
0.3 |
GO:0044253 |
positive regulation of collagen metabolic process(GO:0010714) positive regulation of collagen biosynthetic process(GO:0032967) positive regulation of multicellular organismal metabolic process(GO:0044253) |
| 0.3 |
1.0 |
GO:0060447 |
bud outgrowth involved in lung branching(GO:0060447) |
| 0.3 |
1.3 |
GO:0021764 |
amygdala development(GO:0021764) |
| 0.3 |
1.6 |
GO:1903624 |
regulation of apoptotic DNA fragmentation(GO:1902510) regulation of DNA catabolic process(GO:1903624) |
| 0.3 |
3.6 |
GO:0060707 |
trophoblast giant cell differentiation(GO:0060707) |
| 0.3 |
9.8 |
GO:0034723 |
DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 0.3 |
1.3 |
GO:0048934 |
peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
| 0.3 |
0.3 |
GO:0030422 |
production of siRNA involved in RNA interference(GO:0030422) |
| 0.3 |
0.6 |
GO:0033088 |
negative regulation of immature T cell proliferation in thymus(GO:0033088) |
| 0.3 |
6.1 |
GO:0043968 |
histone H2A acetylation(GO:0043968) |
| 0.3 |
0.3 |
GO:0042359 |
vitamin D metabolic process(GO:0042359) |
| 0.3 |
0.3 |
GO:0036118 |
hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
| 0.3 |
1.9 |
GO:0018195 |
peptidyl-arginine modification(GO:0018195) |
| 0.3 |
1.3 |
GO:0006438 |
valyl-tRNA aminoacylation(GO:0006438) |
| 0.3 |
0.6 |
GO:0090187 |
positive regulation of pancreatic juice secretion(GO:0090187) |
| 0.3 |
1.0 |
GO:0042264 |
peptidyl-aspartic acid hydroxylation(GO:0042264) |
| 0.3 |
1.0 |
GO:0031120 |
snRNA pseudouridine synthesis(GO:0031120) |
| 0.3 |
0.6 |
GO:0060056 |
mammary gland involution(GO:0060056) |
| 0.3 |
0.3 |
GO:0048633 |
positive regulation of skeletal muscle tissue growth(GO:0048633) |
| 0.3 |
1.9 |
GO:0046459 |
short-chain fatty acid metabolic process(GO:0046459) |
| 0.3 |
1.3 |
GO:0043569 |
negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
| 0.3 |
1.6 |
GO:0006987 |
activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
| 0.3 |
0.6 |
GO:2000189 |
positive regulation of cholesterol homeostasis(GO:2000189) |
| 0.3 |
0.9 |
GO:0097527 |
necroptotic signaling pathway(GO:0097527) |
| 0.3 |
1.9 |
GO:0002523 |
leukocyte migration involved in inflammatory response(GO:0002523) |
| 0.3 |
4.3 |
GO:1904293 |
negative regulation of ERAD pathway(GO:1904293) |
| 0.3 |
2.5 |
GO:0060441 |
epithelial tube branching involved in lung morphogenesis(GO:0060441) |
| 0.3 |
1.5 |
GO:0030263 |
apoptotic chromosome condensation(GO:0030263) |
| 0.3 |
1.2 |
GO:0019276 |
UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
| 0.3 |
0.6 |
GO:0007406 |
negative regulation of neuroblast proliferation(GO:0007406) |
| 0.3 |
0.6 |
GO:2000286 |
receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
| 0.3 |
1.2 |
GO:0009435 |
NAD biosynthetic process(GO:0009435) |
| 0.3 |
0.9 |
GO:0071139 |
resolution of recombination intermediates(GO:0071139) |
| 0.3 |
1.2 |
GO:0006977 |
DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
| 0.3 |
3.6 |
GO:1904816 |
positive regulation of protein localization to chromosome, telomeric region(GO:1904816) |
| 0.3 |
0.9 |
GO:0042908 |
xenobiotic transport(GO:0042908) |
| 0.3 |
1.2 |
GO:2000346 |
negative regulation of hepatocyte proliferation(GO:2000346) |
| 0.3 |
2.4 |
GO:0035542 |
regulation of SNARE complex assembly(GO:0035542) |
| 0.3 |
1.8 |
GO:1900262 |
regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 0.3 |
0.3 |
GO:0043278 |
response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
| 0.3 |
2.4 |
GO:0006398 |
mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 0.3 |
1.2 |
GO:2000674 |
regulation of type B pancreatic cell apoptotic process(GO:2000674) |
| 0.3 |
2.1 |
GO:0031536 |
positive regulation of exit from mitosis(GO:0031536) |
| 0.3 |
0.6 |
GO:0002669 |
positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
| 0.3 |
0.6 |
GO:1904030 |
negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
| 0.3 |
2.4 |
GO:0040016 |
embryonic cleavage(GO:0040016) |
| 0.3 |
0.9 |
GO:0089700 |
protein kinase D signaling(GO:0089700) |
| 0.3 |
1.2 |
GO:0006297 |
nucleotide-excision repair, DNA gap filling(GO:0006297) |
| 0.3 |
3.2 |
GO:0003334 |
keratinocyte development(GO:0003334) |
| 0.3 |
2.4 |
GO:0036120 |
response to platelet-derived growth factor(GO:0036119) cellular response to platelet-derived growth factor stimulus(GO:0036120) |
| 0.3 |
5.9 |
GO:0035873 |
lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
| 0.3 |
0.6 |
GO:0007171 |
activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
| 0.3 |
0.9 |
GO:0019085 |
early viral transcription(GO:0019085) |
| 0.3 |
0.3 |
GO:0031914 |
negative regulation of synaptic plasticity(GO:0031914) |
| 0.3 |
2.0 |
GO:0032075 |
positive regulation of nuclease activity(GO:0032075) |
| 0.3 |
5.0 |
GO:0044819 |
mitotic G1/S transition checkpoint(GO:0044819) |
| 0.3 |
9.0 |
GO:0000387 |
spliceosomal snRNP assembly(GO:0000387) |
| 0.3 |
1.4 |
GO:0033262 |
regulation of nuclear cell cycle DNA replication(GO:0033262) |
| 0.3 |
0.3 |
GO:0034502 |
protein localization to chromosome(GO:0034502) |
| 0.3 |
0.6 |
GO:0072697 |
protein localization to cell cortex(GO:0072697) |
| 0.3 |
2.6 |
GO:0010719 |
negative regulation of epithelial to mesenchymal transition(GO:0010719) |
| 0.3 |
1.1 |
GO:0045003 |
DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
| 0.3 |
2.0 |
GO:0045292 |
mRNA cis splicing, via spliceosome(GO:0045292) |
| 0.3 |
1.7 |
GO:0033601 |
positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
| 0.3 |
0.3 |
GO:0034140 |
negative regulation of toll-like receptor 3 signaling pathway(GO:0034140) |
| 0.3 |
2.3 |
GO:0033523 |
histone H2B ubiquitination(GO:0033523) |
| 0.3 |
0.6 |
GO:0070365 |
hepatocyte differentiation(GO:0070365) |
| 0.3 |
2.2 |
GO:0015074 |
DNA integration(GO:0015074) |
| 0.3 |
2.5 |
GO:0060068 |
vagina development(GO:0060068) |
| 0.3 |
0.6 |
GO:0002756 |
MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
| 0.3 |
1.1 |
GO:0034975 |
protein folding in endoplasmic reticulum(GO:0034975) |
| 0.3 |
5.8 |
GO:0008608 |
attachment of spindle microtubules to kinetochore(GO:0008608) |
| 0.3 |
2.8 |
GO:1903332 |
regulation of protein folding(GO:1903332) |
| 0.3 |
0.8 |
GO:0048211 |
Golgi vesicle docking(GO:0048211) |
| 0.3 |
0.6 |
GO:0002082 |
regulation of oxidative phosphorylation(GO:0002082) |
| 0.3 |
1.4 |
GO:0003158 |
endothelium development(GO:0003158) |
| 0.3 |
0.3 |
GO:0071600 |
otic vesicle morphogenesis(GO:0071600) |
| 0.3 |
0.3 |
GO:0072017 |
distal tubule development(GO:0072017) |
| 0.3 |
0.5 |
GO:0051660 |
cortical microtubule organization(GO:0043622) establishment of centrosome localization(GO:0051660) |
| 0.3 |
2.2 |
GO:2000637 |
positive regulation of gene silencing by miRNA(GO:2000637) |
| 0.3 |
1.1 |
GO:0030050 |
vesicle transport along actin filament(GO:0030050) |
| 0.3 |
3.0 |
GO:0051044 |
positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
| 0.3 |
0.5 |
GO:0090283 |
regulation of protein glycosylation in Golgi(GO:0090283) |
| 0.3 |
2.4 |
GO:2000269 |
regulation of fibroblast apoptotic process(GO:2000269) |
| 0.3 |
2.4 |
GO:0021511 |
spinal cord patterning(GO:0021511) |
| 0.3 |
0.8 |
GO:0034724 |
DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
| 0.3 |
0.3 |
GO:0048318 |
axial mesoderm development(GO:0048318) |
| 0.3 |
0.3 |
GO:0003100 |
regulation of systemic arterial blood pressure by endothelin(GO:0003100) |
| 0.3 |
3.4 |
GO:0034508 |
centromere complex assembly(GO:0034508) |
| 0.3 |
0.8 |
GO:0014835 |
myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
| 0.3 |
3.1 |
GO:0000463 |
maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
| 0.3 |
0.8 |
GO:0060024 |
rhythmic synaptic transmission(GO:0060024) |
| 0.3 |
0.5 |
GO:0032682 |
negative regulation of chemokine production(GO:0032682) |
| 0.3 |
2.3 |
GO:0010390 |
histone monoubiquitination(GO:0010390) |
| 0.3 |
1.6 |
GO:1903690 |
negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
| 0.3 |
0.3 |
GO:0002329 |
pre-B cell differentiation(GO:0002329) |
| 0.3 |
22.4 |
GO:0051028 |
mRNA transport(GO:0051028) |
| 0.3 |
2.1 |
GO:0006450 |
regulation of translational fidelity(GO:0006450) |
| 0.3 |
0.5 |
GO:0070307 |
lens fiber cell development(GO:0070307) |
| 0.3 |
0.5 |
GO:0006310 |
DNA recombination(GO:0006310) |
| 0.3 |
0.5 |
GO:2000192 |
negative regulation of fatty acid transport(GO:2000192) |
| 0.3 |
0.5 |
GO:0031990 |
mRNA export from nucleus in response to heat stress(GO:0031990) |
| 0.3 |
1.8 |
GO:0000290 |
deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
| 0.3 |
5.3 |
GO:0009299 |
mRNA transcription(GO:0009299) |
| 0.3 |
1.0 |
GO:0060330 |
regulation of response to interferon-gamma(GO:0060330) |
| 0.3 |
1.3 |
GO:0060430 |
lung saccule development(GO:0060430) |
| 0.3 |
2.0 |
GO:0060065 |
uterus development(GO:0060065) |
| 0.3 |
1.0 |
GO:0014841 |
skeletal muscle satellite cell proliferation(GO:0014841) |
| 0.3 |
0.5 |
GO:0000957 |
mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
| 0.3 |
2.8 |
GO:0009954 |
proximal/distal pattern formation(GO:0009954) |
| 0.3 |
2.0 |
GO:0000963 |
mitochondrial RNA processing(GO:0000963) |
| 0.2 |
2.2 |
GO:0008105 |
asymmetric protein localization(GO:0008105) |
| 0.2 |
2.0 |
GO:0060736 |
prostate gland growth(GO:0060736) |
| 0.2 |
0.7 |
GO:0006309 |
apoptotic DNA fragmentation(GO:0006309) |
| 0.2 |
2.5 |
GO:0045974 |
miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
| 0.2 |
2.0 |
GO:0010225 |
response to UV-C(GO:0010225) |
| 0.2 |
0.5 |
GO:0010940 |
positive regulation of necrotic cell death(GO:0010940) |
| 0.2 |
1.2 |
GO:0021780 |
oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
| 0.2 |
0.7 |
GO:0031116 |
positive regulation of microtubule polymerization(GO:0031116) |
| 0.2 |
1.2 |
GO:0015721 |
bile acid and bile salt transport(GO:0015721) |
| 0.2 |
0.7 |
GO:0032790 |
ribosome disassembly(GO:0032790) |
| 0.2 |
1.0 |
GO:0008616 |
queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
| 0.2 |
1.0 |
GO:0006529 |
asparagine biosynthetic process(GO:0006529) |
| 0.2 |
3.2 |
GO:0071364 |
cellular response to epidermal growth factor stimulus(GO:0071364) |
| 0.2 |
1.0 |
GO:0055099 |
response to high density lipoprotein particle(GO:0055099) |
| 0.2 |
0.2 |
GO:0070245 |
positive regulation of thymocyte apoptotic process(GO:0070245) |
| 0.2 |
3.1 |
GO:0007530 |
sex determination(GO:0007530) |
| 0.2 |
4.8 |
GO:0048025 |
negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
| 0.2 |
1.7 |
GO:0090394 |
negative regulation of excitatory postsynaptic potential(GO:0090394) |
| 0.2 |
3.8 |
GO:2000134 |
negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
| 0.2 |
0.2 |
GO:0019249 |
lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
| 0.2 |
0.2 |
GO:0061179 |
negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 0.2 |
2.4 |
GO:0006924 |
activation-induced cell death of T cells(GO:0006924) |
| 0.2 |
1.0 |
GO:0032439 |
endosome localization(GO:0032439) |
| 0.2 |
1.2 |
GO:0090209 |
negative regulation of triglyceride metabolic process(GO:0090209) |
| 0.2 |
1.2 |
GO:0019065 |
receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
| 0.2 |
5.4 |
GO:0043171 |
peptide catabolic process(GO:0043171) |
| 0.2 |
0.9 |
GO:2001224 |
positive regulation of neuron migration(GO:2001224) |
| 0.2 |
1.4 |
GO:0048733 |
sebaceous gland development(GO:0048733) |
| 0.2 |
3.5 |
GO:0008340 |
determination of adult lifespan(GO:0008340) |
| 0.2 |
4.0 |
GO:0045116 |
protein neddylation(GO:0045116) |
| 0.2 |
1.6 |
GO:0031424 |
keratinization(GO:0031424) |
| 0.2 |
1.2 |
GO:1901409 |
regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
| 0.2 |
1.2 |
GO:0060760 |
positive regulation of response to cytokine stimulus(GO:0060760) |
| 0.2 |
1.4 |
GO:0008611 |
ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) cellular lipid biosynthetic process(GO:0097384) ether biosynthetic process(GO:1901503) |
| 0.2 |
1.2 |
GO:0031860 |
telomeric 3' overhang formation(GO:0031860) |
| 0.2 |
0.7 |
GO:0006379 |
mRNA cleavage(GO:0006379) |
| 0.2 |
0.5 |
GO:1902165 |
regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902165) |
| 0.2 |
0.7 |
GO:0006030 |
chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
| 0.2 |
0.7 |
GO:0042256 |
mature ribosome assembly(GO:0042256) |
| 0.2 |
0.9 |
GO:0046294 |
formaldehyde catabolic process(GO:0046294) |
| 0.2 |
0.9 |
GO:0070966 |
nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
| 0.2 |
0.7 |
GO:0010944 |
negative regulation of transcription by competitive promoter binding(GO:0010944) |
| 0.2 |
0.2 |
GO:0046716 |
muscle cell cellular homeostasis(GO:0046716) |
| 0.2 |
0.7 |
GO:0043456 |
regulation of pentose-phosphate shunt(GO:0043456) |
| 0.2 |
1.1 |
GO:0060297 |
regulation of sarcomere organization(GO:0060297) |
| 0.2 |
0.7 |
GO:0051031 |
tRNA transport(GO:0051031) |
| 0.2 |
0.2 |
GO:0098543 |
detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
| 0.2 |
0.4 |
GO:1903441 |
protein localization to ciliary membrane(GO:1903441) |
| 0.2 |
0.7 |
GO:0060766 |
negative regulation of androgen receptor signaling pathway(GO:0060766) |
| 0.2 |
3.3 |
GO:0098534 |
centriole assembly(GO:0098534) |
| 0.2 |
4.0 |
GO:0046827 |
positive regulation of protein export from nucleus(GO:0046827) |
| 0.2 |
6.4 |
GO:0008156 |
negative regulation of DNA replication(GO:0008156) |
| 0.2 |
1.1 |
GO:0035413 |
positive regulation of catenin import into nucleus(GO:0035413) |
| 0.2 |
2.6 |
GO:0061302 |
smooth muscle cell-matrix adhesion(GO:0061302) |
| 0.2 |
3.7 |
GO:0006613 |
cotranslational protein targeting to membrane(GO:0006613) |
| 0.2 |
0.4 |
GO:2000852 |
regulation of corticosterone secretion(GO:2000852) |
| 0.2 |
2.6 |
GO:0006388 |
tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
| 0.2 |
1.8 |
GO:0031468 |
nuclear envelope reassembly(GO:0031468) |
| 0.2 |
0.4 |
GO:0019441 |
tryptophan catabolic process(GO:0006569) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) kynurenine metabolic process(GO:0070189) |
| 0.2 |
0.7 |
GO:0015772 |
disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 0.2 |
1.5 |
GO:0080009 |
mRNA methylation(GO:0080009) |
| 0.2 |
0.4 |
GO:0032962 |
regulation of inositol trisphosphate biosynthetic process(GO:0032960) positive regulation of inositol trisphosphate biosynthetic process(GO:0032962) |
| 0.2 |
2.2 |
GO:0044381 |
glucose import in response to insulin stimulus(GO:0044381) regulation of glucose import in response to insulin stimulus(GO:2001273) |
| 0.2 |
0.4 |
GO:1901301 |
regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
| 0.2 |
1.5 |
GO:2000258 |
negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
| 0.2 |
7.9 |
GO:0000380 |
alternative mRNA splicing, via spliceosome(GO:0000380) |
| 0.2 |
0.4 |
GO:1903960 |
negative regulation of anion transmembrane transport(GO:1903960) |
| 0.2 |
5.8 |
GO:0006376 |
mRNA splice site selection(GO:0006376) |
| 0.2 |
0.2 |
GO:0045359 |
positive regulation of interferon-beta biosynthetic process(GO:0045359) |
| 0.2 |
0.4 |
GO:0000055 |
ribosomal large subunit export from nucleus(GO:0000055) |
| 0.2 |
0.2 |
GO:0001787 |
natural killer cell proliferation(GO:0001787) |
| 0.2 |
0.8 |
GO:0046060 |
dATP metabolic process(GO:0046060) |
| 0.2 |
1.7 |
GO:0071157 |
negative regulation of cell cycle arrest(GO:0071157) |
| 0.2 |
2.3 |
GO:0016339 |
calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 0.2 |
0.4 |
GO:0046668 |
regulation of retinal cell programmed cell death(GO:0046668) |
| 0.2 |
2.5 |
GO:0040034 |
regulation of development, heterochronic(GO:0040034) |
| 0.2 |
1.1 |
GO:0042769 |
DNA damage response, detection of DNA damage(GO:0042769) |
| 0.2 |
1.9 |
GO:0071447 |
cellular response to hydroperoxide(GO:0071447) |
| 0.2 |
0.4 |
GO:0008594 |
photoreceptor cell morphogenesis(GO:0008594) |
| 0.2 |
0.8 |
GO:0051088 |
PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
| 0.2 |
0.6 |
GO:0015960 |
diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
| 0.2 |
0.6 |
GO:0021691 |
cerebellar Purkinje cell layer maturation(GO:0021691) |
| 0.2 |
1.2 |
GO:0051418 |
interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
| 0.2 |
0.6 |
GO:0045053 |
protein retention in Golgi apparatus(GO:0045053) |
| 0.2 |
0.4 |
GO:0006703 |
estrogen biosynthetic process(GO:0006703) |
| 0.2 |
0.4 |
GO:0048636 |
positive regulation of striated muscle tissue development(GO:0045844) positive regulation of muscle organ development(GO:0048636) positive regulation of muscle tissue development(GO:1901863) |
| 0.2 |
0.6 |
GO:1902913 |
positive regulation of melanocyte differentiation(GO:0045636) positive regulation of neuroepithelial cell differentiation(GO:1902913) |
| 0.2 |
1.0 |
GO:0007221 |
positive regulation of transcription of Notch receptor target(GO:0007221) |
| 0.2 |
5.4 |
GO:0034605 |
cellular response to heat(GO:0034605) |
| 0.2 |
0.2 |
GO:1901889 |
negative regulation of cell junction assembly(GO:1901889) |
| 0.2 |
0.4 |
GO:0009880 |
embryonic pattern specification(GO:0009880) |
| 0.2 |
2.7 |
GO:0050892 |
intestinal absorption(GO:0050892) |
| 0.2 |
2.5 |
GO:0051443 |
positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
| 0.2 |
0.4 |
GO:0045647 |
negative regulation of erythrocyte differentiation(GO:0045647) |
| 0.2 |
2.0 |
GO:0019262 |
N-acetylneuraminate catabolic process(GO:0019262) |
| 0.2 |
1.8 |
GO:0043966 |
histone H3 acetylation(GO:0043966) |
| 0.2 |
2.2 |
GO:0034773 |
histone H4-K20 methylation(GO:0034770) histone H4-K20 trimethylation(GO:0034773) |
| 0.2 |
20.6 |
GO:0000375 |
RNA splicing, via transesterification reactions(GO:0000375) |
| 0.2 |
0.4 |
GO:0040038 |
polar body extrusion after meiotic divisions(GO:0040038) |
| 0.2 |
0.6 |
GO:0044861 |
protein transport into plasma membrane raft(GO:0044861) |
| 0.2 |
0.6 |
GO:0015793 |
glycerol transport(GO:0015793) |
| 0.2 |
0.2 |
GO:0010533 |
regulation of activation of Janus kinase activity(GO:0010533) regulation of activation of JAK2 kinase activity(GO:0010534) |
| 0.2 |
0.8 |
GO:0007064 |
mitotic sister chromatid cohesion(GO:0007064) |
| 0.2 |
1.6 |
GO:0002467 |
germinal center formation(GO:0002467) |
| 0.2 |
1.2 |
GO:0030035 |
microspike assembly(GO:0030035) |
| 0.2 |
0.4 |
GO:0030950 |
establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
| 0.2 |
1.2 |
GO:0007175 |
negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
| 0.2 |
1.4 |
GO:0048251 |
elastic fiber assembly(GO:0048251) |
| 0.2 |
0.6 |
GO:0042097 |
interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
| 0.2 |
0.4 |
GO:0046121 |
deoxyribonucleoside catabolic process(GO:0046121) |
| 0.2 |
0.8 |
GO:1902775 |
mitochondrial large ribosomal subunit assembly(GO:1902775) |
| 0.2 |
2.7 |
GO:0042149 |
cellular response to glucose starvation(GO:0042149) |
| 0.2 |
0.6 |
GO:0036462 |
TRAIL-activated apoptotic signaling pathway(GO:0036462) |
| 0.2 |
0.2 |
GO:0033085 |
negative regulation of T cell differentiation in thymus(GO:0033085) negative regulation of thymocyte aggregation(GO:2000399) |
| 0.2 |
3.5 |
GO:0007492 |
endoderm development(GO:0007492) |
| 0.2 |
0.6 |
GO:0097011 |
cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) |
| 0.2 |
7.5 |
GO:0000462 |
maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
| 0.2 |
1.7 |
GO:0018065 |
protein-cofactor linkage(GO:0018065) |
| 0.2 |
0.2 |
GO:0006295 |
nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
| 0.2 |
0.6 |
GO:0075525 |
viral translational termination-reinitiation(GO:0075525) |
| 0.2 |
2.3 |
GO:0019471 |
4-hydroxyproline metabolic process(GO:0019471) |
| 0.2 |
0.6 |
GO:0048386 |
positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 0.2 |
0.4 |
GO:0002200 |
somatic diversification of immune receptors(GO:0002200) |
| 0.2 |
4.6 |
GO:0007091 |
metaphase/anaphase transition of mitotic cell cycle(GO:0007091) regulation of mitotic sister chromatid separation(GO:0010965) metaphase/anaphase transition of cell cycle(GO:0044784) |
| 0.2 |
0.6 |
GO:0003148 |
outflow tract septum morphogenesis(GO:0003148) |
| 0.2 |
0.4 |
GO:0018214 |
peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
| 0.2 |
1.3 |
GO:0060325 |
face morphogenesis(GO:0060325) |
| 0.2 |
0.8 |
GO:0036506 |
maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
| 0.2 |
1.3 |
GO:0031297 |
replication fork processing(GO:0031297) |
| 0.2 |
1.3 |
GO:0090344 |
negative regulation of cell aging(GO:0090344) |
| 0.2 |
2.6 |
GO:0002385 |
mucosal immune response(GO:0002385) |
| 0.2 |
0.4 |
GO:0090085 |
regulation of protein deubiquitination(GO:0090085) |
| 0.2 |
1.9 |
GO:0044380 |
protein localization to cytoskeleton(GO:0044380) |
| 0.2 |
0.2 |
GO:1901796 |
regulation of signal transduction by p53 class mediator(GO:1901796) |
| 0.2 |
1.5 |
GO:0019363 |
pyridine nucleotide biosynthetic process(GO:0019363) |
| 0.2 |
2.8 |
GO:0042407 |
cristae formation(GO:0042407) |
| 0.2 |
0.6 |
GO:0044565 |
dendritic cell proliferation(GO:0044565) |
| 0.2 |
0.9 |
GO:0006167 |
AMP biosynthetic process(GO:0006167) |
| 0.2 |
0.2 |
GO:1902414 |
protein localization to cell junction(GO:1902414) |
| 0.2 |
0.6 |
GO:1901097 |
negative regulation of autophagosome maturation(GO:1901097) |
| 0.2 |
0.4 |
GO:0072610 |
interleukin-12 secretion(GO:0072610) regulation of interleukin-12 secretion(GO:2001182) positive regulation of interleukin-12 secretion(GO:2001184) |
| 0.2 |
0.4 |
GO:0000722 |
telomere maintenance via recombination(GO:0000722) |
| 0.2 |
1.3 |
GO:0030011 |
maintenance of cell polarity(GO:0030011) |
| 0.2 |
4.1 |
GO:0000027 |
ribosomal large subunit assembly(GO:0000027) |
| 0.2 |
0.4 |
GO:1902031 |
regulation of NADP metabolic process(GO:1902031) |
| 0.2 |
0.2 |
GO:0032275 |
luteinizing hormone secretion(GO:0032275) |
| 0.2 |
0.9 |
GO:0048706 |
embryonic skeletal system development(GO:0048706) |
| 0.2 |
0.4 |
GO:0002578 |
negative regulation of antigen processing and presentation(GO:0002578) |
| 0.2 |
0.4 |
GO:0006268 |
DNA unwinding involved in DNA replication(GO:0006268) |
| 0.2 |
0.4 |
GO:1903608 |
protein localization to cytoplasmic stress granule(GO:1903608) |
| 0.2 |
1.1 |
GO:0019321 |
pentose metabolic process(GO:0019321) |
| 0.2 |
4.7 |
GO:0010501 |
RNA secondary structure unwinding(GO:0010501) |
| 0.2 |
1.1 |
GO:1903847 |
regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
| 0.2 |
0.4 |
GO:0003161 |
cardiac conduction system development(GO:0003161) |
| 0.2 |
0.5 |
GO:0002903 |
negative regulation of B cell apoptotic process(GO:0002903) |
| 0.2 |
4.9 |
GO:0021591 |
ventricular system development(GO:0021591) |
| 0.2 |
0.7 |
GO:0072362 |
regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter(GO:0072361) regulation of glycolytic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072362) |
| 0.2 |
0.2 |
GO:0090035 |
regulation of chaperone-mediated protein complex assembly(GO:0090034) positive regulation of chaperone-mediated protein complex assembly(GO:0090035) |
| 0.2 |
0.9 |
GO:0060040 |
retinal bipolar neuron differentiation(GO:0060040) |
| 0.2 |
0.7 |
GO:0055070 |
copper ion homeostasis(GO:0055070) |
| 0.2 |
1.1 |
GO:1902894 |
negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
| 0.2 |
0.4 |
GO:0035521 |
monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
| 0.2 |
1.2 |
GO:0031119 |
tRNA pseudouridine synthesis(GO:0031119) |
| 0.2 |
1.9 |
GO:0034453 |
microtubule anchoring(GO:0034453) |
| 0.2 |
0.2 |
GO:0034316 |
negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
| 0.2 |
0.5 |
GO:0007379 |
segment specification(GO:0007379) |
| 0.2 |
1.0 |
GO:0033353 |
S-adenosylmethionine cycle(GO:0033353) |
| 0.2 |
0.3 |
GO:0060352 |
cell adhesion molecule production(GO:0060352) |
| 0.2 |
0.7 |
GO:0006573 |
valine metabolic process(GO:0006573) |
| 0.2 |
0.7 |
GO:0042447 |
hormone catabolic process(GO:0042447) |
| 0.2 |
0.7 |
GO:0051409 |
response to nitrosative stress(GO:0051409) |
| 0.2 |
0.5 |
GO:0045743 |
positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
| 0.2 |
0.7 |
GO:2001270 |
regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
| 0.2 |
0.9 |
GO:0035405 |
histone-threonine phosphorylation(GO:0035405) |
| 0.2 |
0.5 |
GO:2000973 |
regulation of pro-B cell differentiation(GO:2000973) |
| 0.2 |
3.9 |
GO:0002181 |
cytoplasmic translation(GO:0002181) |
| 0.2 |
1.0 |
GO:0051461 |
corticotropin secretion(GO:0051458) regulation of corticotropin secretion(GO:0051459) positive regulation of corticotropin secretion(GO:0051461) |
| 0.2 |
3.7 |
GO:0030488 |
tRNA methylation(GO:0030488) |
| 0.2 |
0.3 |
GO:0070932 |
histone H3 deacetylation(GO:0070932) |
| 0.2 |
2.2 |
GO:0035020 |
regulation of Rac protein signal transduction(GO:0035020) |
| 0.2 |
1.7 |
GO:0001947 |
heart looping(GO:0001947) |
| 0.2 |
0.5 |
GO:0042790 |
transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:0042790) |
| 0.2 |
0.3 |
GO:1904251 |
regulation of bile acid metabolic process(GO:1904251) |
| 0.2 |
2.7 |
GO:0072673 |
lamellipodium morphogenesis(GO:0072673) |
| 0.2 |
0.2 |
GO:0060166 |
olfactory pit development(GO:0060166) |
| 0.2 |
3.2 |
GO:0035567 |
non-canonical Wnt signaling pathway(GO:0035567) |
| 0.2 |
1.7 |
GO:0006560 |
proline metabolic process(GO:0006560) |
| 0.2 |
12.8 |
GO:0006413 |
translational initiation(GO:0006413) |
| 0.2 |
1.2 |
GO:0045793 |
positive regulation of cell size(GO:0045793) |
| 0.2 |
0.3 |
GO:0035973 |
aggrephagy(GO:0035973) |
| 0.2 |
0.3 |
GO:0051305 |
chromosome movement towards spindle pole(GO:0051305) |
| 0.2 |
0.8 |
GO:0030224 |
monocyte differentiation(GO:0030224) |
| 0.2 |
0.8 |
GO:0002088 |
lens development in camera-type eye(GO:0002088) |
| 0.2 |
1.1 |
GO:0006968 |
cellular defense response(GO:0006968) |
| 0.2 |
1.3 |
GO:0071971 |
extracellular exosome assembly(GO:0071971) regulation of extracellular exosome assembly(GO:1903551) |
| 0.2 |
7.9 |
GO:0043484 |
regulation of RNA splicing(GO:0043484) |
| 0.2 |
2.1 |
GO:0030150 |
protein import into mitochondrial matrix(GO:0030150) |
| 0.2 |
1.4 |
GO:0001779 |
natural killer cell differentiation(GO:0001779) |
| 0.2 |
0.8 |
GO:0006564 |
L-serine biosynthetic process(GO:0006564) |
| 0.2 |
0.5 |
GO:0048739 |
cardiac muscle fiber development(GO:0048739) |
| 0.2 |
0.8 |
GO:0045086 |
positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
| 0.2 |
2.9 |
GO:1902043 |
positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
| 0.2 |
0.2 |
GO:0006264 |
mitochondrial DNA replication(GO:0006264) |
| 0.2 |
0.3 |
GO:0043517 |
positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
| 0.2 |
1.6 |
GO:0001522 |
pseudouridine synthesis(GO:0001522) |
| 0.2 |
0.5 |
GO:0006553 |
lysine metabolic process(GO:0006553) |
| 0.2 |
0.3 |
GO:0060763 |
mammary duct terminal end bud growth(GO:0060763) |
| 0.2 |
3.1 |
GO:0000154 |
rRNA modification(GO:0000154) |
| 0.2 |
0.9 |
GO:0070979 |
protein K11-linked ubiquitination(GO:0070979) |
| 0.2 |
0.5 |
GO:0046032 |
ADP catabolic process(GO:0046032) IDP metabolic process(GO:0046707) IDP catabolic process(GO:0046709) |
| 0.2 |
0.2 |
GO:0009957 |
epidermal cell fate specification(GO:0009957) |
| 0.2 |
0.6 |
GO:0071475 |
cellular hyperosmotic salinity response(GO:0071475) double-strand break repair via classical nonhomologous end joining(GO:0097680) |
| 0.2 |
2.6 |
GO:0006825 |
copper ion transport(GO:0006825) |
| 0.2 |
1.1 |
GO:0002011 |
morphogenesis of an epithelial sheet(GO:0002011) |
| 0.2 |
0.3 |
GO:0030853 |
negative regulation of granulocyte differentiation(GO:0030853) negative regulation of macrophage differentiation(GO:0045650) |
| 0.2 |
0.3 |
GO:2000059 |
negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
| 0.2 |
3.4 |
GO:0035458 |
cellular response to interferon-beta(GO:0035458) |
| 0.2 |
0.6 |
GO:1900220 |
semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
| 0.2 |
1.1 |
GO:1900119 |
positive regulation of execution phase of apoptosis(GO:1900119) |
| 0.2 |
0.5 |
GO:1900016 |
negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
| 0.2 |
1.2 |
GO:2000380 |
regulation of mesoderm development(GO:2000380) |
| 0.2 |
1.2 |
GO:0048672 |
positive regulation of collateral sprouting(GO:0048672) |
| 0.2 |
0.5 |
GO:0000466 |
maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000466) |
| 0.2 |
0.3 |
GO:0090148 |
membrane fission(GO:0090148) |
| 0.2 |
0.9 |
GO:0045218 |
zonula adherens maintenance(GO:0045218) |
| 0.1 |
0.6 |
GO:0042095 |
interferon-gamma biosynthetic process(GO:0042095) |
| 0.1 |
0.1 |
GO:0018126 |
protein hydroxylation(GO:0018126) |
| 0.1 |
0.4 |
GO:0009644 |
response to high light intensity(GO:0009644) |
| 0.1 |
0.7 |
GO:0006730 |
one-carbon metabolic process(GO:0006730) |
| 0.1 |
2.6 |
GO:0001658 |
branching involved in ureteric bud morphogenesis(GO:0001658) |
| 0.1 |
0.3 |
GO:0097411 |
hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
| 0.1 |
5.9 |
GO:0051225 |
spindle assembly(GO:0051225) |
| 0.1 |
8.2 |
GO:0008033 |
tRNA processing(GO:0008033) |
| 0.1 |
0.4 |
GO:0001302 |
replicative cell aging(GO:0001302) |
| 0.1 |
2.8 |
GO:0003301 |
physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.1 |
0.3 |
GO:0001923 |
B-1 B cell differentiation(GO:0001923) |
| 0.1 |
0.6 |
GO:0031937 |
positive regulation of chromatin silencing(GO:0031937) |
| 0.1 |
3.3 |
GO:0016925 |
protein sumoylation(GO:0016925) |
| 0.1 |
0.6 |
GO:0005981 |
regulation of glycogen catabolic process(GO:0005981) |
| 0.1 |
0.3 |
GO:0071679 |
commissural neuron axon guidance(GO:0071679) |
| 0.1 |
0.9 |
GO:0043267 |
negative regulation of potassium ion transport(GO:0043267) |
| 0.1 |
2.0 |
GO:0000470 |
maturation of LSU-rRNA(GO:0000470) |
| 0.1 |
2.1 |
GO:0046329 |
negative regulation of JNK cascade(GO:0046329) |
| 0.1 |
0.1 |
GO:0006401 |
RNA catabolic process(GO:0006401) |
| 0.1 |
0.4 |
GO:0006435 |
threonyl-tRNA aminoacylation(GO:0006435) |
| 0.1 |
0.4 |
GO:0006547 |
histidine metabolic process(GO:0006547) |
| 0.1 |
0.1 |
GO:0001920 |
negative regulation of receptor recycling(GO:0001920) |
| 0.1 |
0.4 |
GO:0030327 |
prenylated protein catabolic process(GO:0030327) |
| 0.1 |
0.6 |
GO:1904587 |
glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
| 0.1 |
1.5 |
GO:0034312 |
diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) sphingoid biosynthetic process(GO:0046520) |
| 0.1 |
1.1 |
GO:0030490 |
maturation of SSU-rRNA(GO:0030490) |
| 0.1 |
0.4 |
GO:2000323 |
negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
| 0.1 |
0.4 |
GO:0030647 |
polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
| 0.1 |
0.6 |
GO:0006451 |
selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
| 0.1 |
0.7 |
GO:0009950 |
dorsal/ventral axis specification(GO:0009950) |
| 0.1 |
0.3 |
GO:0070127 |
tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
| 0.1 |
1.0 |
GO:0000184 |
nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
| 0.1 |
0.3 |
GO:0002052 |
positive regulation of neuroblast proliferation(GO:0002052) |
| 0.1 |
1.7 |
GO:2000251 |
positive regulation of actin cytoskeleton reorganization(GO:2000251) |
| 0.1 |
0.4 |
GO:0030865 |
cortical cytoskeleton organization(GO:0030865) |
| 0.1 |
0.3 |
GO:0043162 |
ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
| 0.1 |
0.5 |
GO:0010387 |
COP9 signalosome assembly(GO:0010387) |
| 0.1 |
1.1 |
GO:0035115 |
embryonic forelimb morphogenesis(GO:0035115) |
| 0.1 |
0.1 |
GO:0043368 |
positive T cell selection(GO:0043368) positive thymic T cell selection(GO:0045059) |
| 0.1 |
0.3 |
GO:0006610 |
ribosomal protein import into nucleus(GO:0006610) |
| 0.1 |
1.1 |
GO:0000028 |
ribosomal small subunit assembly(GO:0000028) |
| 0.1 |
0.9 |
GO:0006517 |
protein deglycosylation(GO:0006517) |
| 0.1 |
1.5 |
GO:0018206 |
peptidyl-methionine modification(GO:0018206) |
| 0.1 |
0.8 |
GO:0007131 |
reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
| 0.1 |
0.8 |
GO:0042744 |
hydrogen peroxide catabolic process(GO:0042744) |
| 0.1 |
0.4 |
GO:0070816 |
phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
| 0.1 |
0.4 |
GO:0070327 |
thyroid hormone transport(GO:0070327) |
| 0.1 |
0.4 |
GO:0006556 |
S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.1 |
0.4 |
GO:0002643 |
regulation of tolerance induction(GO:0002643) |
| 0.1 |
0.4 |
GO:1903321 |
negative regulation of protein modification by small protein conjugation or removal(GO:1903321) |
| 0.1 |
0.8 |
GO:0002063 |
chondrocyte development(GO:0002063) |
| 0.1 |
0.9 |
GO:0042590 |
antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
| 0.1 |
1.0 |
GO:0006471 |
protein ADP-ribosylation(GO:0006471) |
| 0.1 |
0.7 |
GO:2000491 |
positive regulation of hepatic stellate cell activation(GO:2000491) |
| 0.1 |
0.5 |
GO:0060236 |
regulation of mitotic spindle organization(GO:0060236) |
| 0.1 |
0.4 |
GO:0001937 |
negative regulation of endothelial cell proliferation(GO:0001937) |
| 0.1 |
1.0 |
GO:0009263 |
deoxyribonucleotide biosynthetic process(GO:0009263) |
| 0.1 |
0.1 |
GO:0060338 |
regulation of type I interferon-mediated signaling pathway(GO:0060338) |
| 0.1 |
2.6 |
GO:0008631 |
intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) |
| 0.1 |
0.4 |
GO:0035162 |
embryonic hemopoiesis(GO:0035162) |
| 0.1 |
0.4 |
GO:0019478 |
D-amino acid catabolic process(GO:0019478) |
| 0.1 |
0.8 |
GO:0050684 |
regulation of mRNA processing(GO:0050684) |
| 0.1 |
0.5 |
GO:0018202 |
peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) peptidyl-histidine modification(GO:0018202) |
| 0.1 |
0.4 |
GO:0001773 |
myeloid dendritic cell activation(GO:0001773) myeloid dendritic cell differentiation(GO:0043011) |
| 0.1 |
3.0 |
GO:0045599 |
negative regulation of fat cell differentiation(GO:0045599) |
| 0.1 |
0.9 |
GO:0034244 |
negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
| 0.1 |
0.3 |
GO:0060672 |
epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 0.1 |
0.2 |
GO:0048711 |
positive regulation of astrocyte differentiation(GO:0048711) |
| 0.1 |
0.2 |
GO:0034729 |
histone H3-K79 methylation(GO:0034729) |
| 0.1 |
0.2 |
GO:0000279 |
M phase(GO:0000279) |
| 0.1 |
0.4 |
GO:0031987 |
locomotion involved in locomotory behavior(GO:0031987) |
| 0.1 |
0.2 |
GO:0007217 |
tachykinin receptor signaling pathway(GO:0007217) |
| 0.1 |
1.7 |
GO:0030513 |
positive regulation of BMP signaling pathway(GO:0030513) |
| 0.1 |
0.6 |
GO:0006627 |
protein processing involved in protein targeting to mitochondrion(GO:0006627) |
| 0.1 |
0.5 |
GO:0043615 |
astrocyte cell migration(GO:0043615) |
| 0.1 |
0.7 |
GO:1902369 |
negative regulation of RNA catabolic process(GO:1902369) |
| 0.1 |
1.0 |
GO:0071229 |
cellular response to acid chemical(GO:0071229) |
| 0.1 |
2.9 |
GO:2000573 |
positive regulation of DNA biosynthetic process(GO:2000573) |
| 0.1 |
0.7 |
GO:0090527 |
actin filament reorganization(GO:0090527) |
| 0.1 |
0.1 |
GO:0006501 |
C-terminal protein lipidation(GO:0006501) |
| 0.1 |
0.5 |
GO:0035743 |
CD4-positive, alpha-beta T cell cytokine production(GO:0035743) T-helper 2 cell cytokine production(GO:0035745) |
| 0.1 |
0.8 |
GO:0003084 |
positive regulation of systemic arterial blood pressure(GO:0003084) |
| 0.1 |
0.5 |
GO:0036342 |
post-anal tail morphogenesis(GO:0036342) |
| 0.1 |
2.2 |
GO:0042462 |
eye photoreceptor cell development(GO:0042462) |
| 0.1 |
0.4 |
GO:0071596 |
ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
| 0.1 |
0.8 |
GO:0006122 |
mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
| 0.1 |
0.1 |
GO:2000630 |
positive regulation of miRNA metabolic process(GO:2000630) |
| 0.1 |
0.6 |
GO:0019254 |
carnitine metabolic process, CoA-linked(GO:0019254) |
| 0.1 |
0.2 |
GO:0030277 |
maintenance of gastrointestinal epithelium(GO:0030277) |
| 0.1 |
0.8 |
GO:0007252 |
I-kappaB phosphorylation(GO:0007252) |
| 0.1 |
1.7 |
GO:2000249 |
regulation of actin cytoskeleton reorganization(GO:2000249) |
| 0.1 |
0.1 |
GO:0001826 |
inner cell mass cell differentiation(GO:0001826) |
| 0.1 |
0.1 |
GO:0034035 |
purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
| 0.1 |
0.7 |
GO:0009235 |
cobalamin metabolic process(GO:0009235) |
| 0.1 |
2.0 |
GO:0007127 |
meiosis I(GO:0007127) |
| 0.1 |
1.4 |
GO:0042273 |
ribosomal large subunit biogenesis(GO:0042273) |
| 0.1 |
0.1 |
GO:0048630 |
skeletal muscle tissue growth(GO:0048630) |
| 0.1 |
1.6 |
GO:0030497 |
fatty acid elongation(GO:0030497) |
| 0.1 |
0.6 |
GO:0071470 |
cellular response to osmotic stress(GO:0071470) |
| 0.1 |
0.5 |
GO:0090103 |
cochlea morphogenesis(GO:0090103) |
| 0.1 |
1.2 |
GO:0060009 |
Sertoli cell development(GO:0060009) |
| 0.1 |
0.2 |
GO:1903378 |
positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
| 0.1 |
0.4 |
GO:0071294 |
cellular response to zinc ion(GO:0071294) |
| 0.1 |
0.2 |
GO:1902219 |
regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
| 0.1 |
0.3 |
GO:0006657 |
CDP-choline pathway(GO:0006657) |
| 0.1 |
0.4 |
GO:0035136 |
forelimb morphogenesis(GO:0035136) |
| 0.1 |
0.2 |
GO:0070837 |
dehydroascorbic acid transport(GO:0070837) |
| 0.1 |
0.1 |
GO:0002051 |
osteoblast fate commitment(GO:0002051) |
| 0.1 |
1.0 |
GO:2000009 |
negative regulation of protein localization to cell surface(GO:2000009) |
| 0.1 |
0.6 |
GO:0090205 |
positive regulation of cholesterol biosynthetic process(GO:0045542) positive regulation of cholesterol metabolic process(GO:0090205) |
| 0.1 |
10.1 |
GO:0006417 |
regulation of translation(GO:0006417) |
| 0.1 |
0.7 |
GO:0001672 |
regulation of chromatin assembly or disassembly(GO:0001672) |
| 0.1 |
2.7 |
GO:0018345 |
protein palmitoylation(GO:0018345) |
| 0.1 |
1.2 |
GO:0097062 |
dendritic spine maintenance(GO:0097062) |
| 0.1 |
5.4 |
GO:0006334 |
nucleosome assembly(GO:0006334) |
| 0.1 |
0.1 |
GO:0060700 |
regulation of ribonuclease activity(GO:0060700) |
| 0.1 |
0.3 |
GO:0006428 |
isoleucyl-tRNA aminoacylation(GO:0006428) |
| 0.1 |
0.1 |
GO:0072015 |
glomerular visceral epithelial cell development(GO:0072015) glomerular epithelial cell development(GO:0072310) |
| 0.1 |
0.6 |
GO:0035562 |
negative regulation of chromatin binding(GO:0035562) |
| 0.1 |
0.4 |
GO:0070126 |
mitochondrial translational termination(GO:0070126) |
| 0.1 |
0.5 |
GO:0035469 |
determination of pancreatic left/right asymmetry(GO:0035469) determination of liver left/right asymmetry(GO:0071910) |
| 0.1 |
1.3 |
GO:0071346 |
cellular response to interferon-gamma(GO:0071346) |
| 0.1 |
0.2 |
GO:0042536 |
negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
| 0.1 |
1.1 |
GO:0010259 |
multicellular organism aging(GO:0010259) |
| 0.1 |
0.4 |
GO:2001256 |
regulation of store-operated calcium entry(GO:2001256) |
| 0.1 |
0.9 |
GO:0030901 |
midbrain development(GO:0030901) |
| 0.1 |
0.7 |
GO:0006221 |
pyrimidine nucleotide biosynthetic process(GO:0006221) |
| 0.1 |
0.3 |
GO:0006097 |
glyoxylate cycle(GO:0006097) glyoxylate metabolic process(GO:0046487) |
| 0.1 |
0.2 |
GO:0070562 |
regulation of vitamin D receptor signaling pathway(GO:0070562) |
| 0.1 |
0.3 |
GO:0097089 |
methyl-branched fatty acid metabolic process(GO:0097089) |
| 0.1 |
0.4 |
GO:1904008 |
cellular response to salt(GO:1902075) response to monosodium glutamate(GO:1904008) cellular response to monosodium glutamate(GO:1904009) |
| 0.1 |
0.5 |
GO:0030952 |
establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) establishment or maintenance of cytoskeleton polarity(GO:0030952) |
| 0.1 |
0.9 |
GO:0010664 |
negative regulation of striated muscle cell apoptotic process(GO:0010664) |
| 0.1 |
0.2 |
GO:0048009 |
insulin-like growth factor receptor signaling pathway(GO:0048009) |
| 0.1 |
0.6 |
GO:0010172 |
embryonic body morphogenesis(GO:0010172) |
| 0.1 |
0.3 |
GO:0060416 |
response to growth hormone(GO:0060416) |
| 0.1 |
0.5 |
GO:0017145 |
stem cell division(GO:0017145) |
| 0.1 |
0.3 |
GO:0071699 |
olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
| 0.1 |
0.3 |
GO:0072176 |
nephric duct development(GO:0072176) nephric duct morphogenesis(GO:0072178) |
| 0.1 |
0.4 |
GO:0031133 |
regulation of axon diameter(GO:0031133) |
| 0.1 |
0.6 |
GO:0051057 |
positive regulation of small GTPase mediated signal transduction(GO:0051057) |
| 0.1 |
0.2 |
GO:0014063 |
negative regulation of serotonin secretion(GO:0014063) |
| 0.1 |
0.9 |
GO:0010388 |
cullin deneddylation(GO:0010388) |
| 0.1 |
0.4 |
GO:0001867 |
complement activation, lectin pathway(GO:0001867) |
| 0.1 |
0.2 |
GO:0007320 |
insemination(GO:0007320) |
| 0.1 |
2.0 |
GO:0000186 |
activation of MAPKK activity(GO:0000186) |
| 0.1 |
0.4 |
GO:0072584 |
caveolin-mediated endocytosis(GO:0072584) |
| 0.1 |
1.0 |
GO:0033209 |
tumor necrosis factor-mediated signaling pathway(GO:0033209) |
| 0.1 |
2.1 |
GO:0043631 |
RNA polyadenylation(GO:0043631) |
| 0.1 |
0.3 |
GO:0061299 |
retina vasculature morphogenesis in camera-type eye(GO:0061299) |
| 0.1 |
0.3 |
GO:2000177 |
regulation of neural precursor cell proliferation(GO:2000177) |
| 0.1 |
0.3 |
GO:0070933 |
histone H4 deacetylation(GO:0070933) |
| 0.1 |
0.3 |
GO:0002002 |
regulation of angiotensin levels in blood(GO:0002002) |
| 0.1 |
0.7 |
GO:0030213 |
hyaluronan biosynthetic process(GO:0030213) |
| 0.1 |
0.4 |
GO:0036337 |
Fas signaling pathway(GO:0036337) |
| 0.1 |
0.5 |
GO:0003085 |
negative regulation of systemic arterial blood pressure(GO:0003085) |
| 0.1 |
1.6 |
GO:0001578 |
microtubule bundle formation(GO:0001578) |
| 0.1 |
1.9 |
GO:0061640 |
cytoskeleton-dependent cytokinesis(GO:0061640) |
| 0.1 |
0.2 |
GO:0071763 |
nuclear membrane organization(GO:0071763) |
| 0.1 |
0.4 |
GO:0032204 |
regulation of telomere maintenance(GO:0032204) |
| 0.1 |
0.3 |
GO:1903300 |
negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
| 0.1 |
0.5 |
GO:0035493 |
SNARE complex assembly(GO:0035493) |
| 0.1 |
0.2 |
GO:2000643 |
positive regulation of early endosome to late endosome transport(GO:2000643) |
| 0.1 |
1.2 |
GO:0007216 |
G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
| 0.1 |
1.9 |
GO:0050830 |
defense response to Gram-positive bacterium(GO:0050830) |
| 0.1 |
12.1 |
GO:0006281 |
DNA repair(GO:0006281) |
| 0.1 |
0.3 |
GO:1902224 |
cellular ketone body metabolic process(GO:0046950) ketone body metabolic process(GO:1902224) |
| 0.1 |
0.3 |
GO:0034243 |
regulation of transcription elongation from RNA polymerase II promoter(GO:0034243) |
| 0.1 |
0.1 |
GO:2000170 |
positive regulation of peptidyl-cysteine S-nitrosylation(GO:2000170) |
| 0.1 |
0.7 |
GO:0048642 |
negative regulation of skeletal muscle tissue development(GO:0048642) |
| 0.1 |
0.4 |
GO:0032801 |
receptor catabolic process(GO:0032801) |
| 0.1 |
1.2 |
GO:0006743 |
ubiquinone metabolic process(GO:0006743) |
| 0.1 |
0.1 |
GO:0034370 |
triglyceride-rich lipoprotein particle remodeling(GO:0034370) |
| 0.1 |
0.1 |
GO:0010637 |
negative regulation of mitochondrial fusion(GO:0010637) |
| 0.1 |
0.4 |
GO:0045662 |
negative regulation of myoblast differentiation(GO:0045662) |
| 0.1 |
0.8 |
GO:0050909 |
sensory perception of taste(GO:0050909) |
| 0.1 |
2.8 |
GO:0016126 |
sterol biosynthetic process(GO:0016126) |
| 0.1 |
0.1 |
GO:0006108 |
malate metabolic process(GO:0006108) |
| 0.1 |
0.4 |
GO:0019730 |
antimicrobial humoral response(GO:0019730) |
| 0.1 |
0.4 |
GO:0043984 |
histone H4-K16 acetylation(GO:0043984) |
| 0.1 |
0.3 |
GO:0048873 |
homeostasis of number of cells within a tissue(GO:0048873) |
| 0.1 |
0.3 |
GO:1903288 |
regulation of potassium ion import(GO:1903286) positive regulation of potassium ion import(GO:1903288) |
| 0.1 |
0.1 |
GO:2001170 |
negative regulation of ATP biosynthetic process(GO:2001170) |
| 0.1 |
0.2 |
GO:0006591 |
ornithine metabolic process(GO:0006591) |
| 0.1 |
0.6 |
GO:0006261 |
DNA-dependent DNA replication(GO:0006261) |
| 0.1 |
0.7 |
GO:0006103 |
2-oxoglutarate metabolic process(GO:0006103) |
| 0.1 |
0.3 |
GO:0048861 |
leukemia inhibitory factor signaling pathway(GO:0048861) |
| 0.1 |
0.3 |
GO:0031047 |
gene silencing by RNA(GO:0031047) |
| 0.1 |
0.2 |
GO:0071557 |
histone H3-K27 demethylation(GO:0071557) |
| 0.1 |
0.3 |
GO:0014722 |
regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
| 0.1 |
0.1 |
GO:0007028 |
cytoplasm organization(GO:0007028) |
| 0.1 |
0.2 |
GO:0097623 |
potassium ion export across plasma membrane(GO:0097623) regulation of potassium ion export(GO:1902302) |
| 0.1 |
0.3 |
GO:0042274 |
ribosomal small subunit biogenesis(GO:0042274) |
| 0.1 |
0.7 |
GO:0021854 |
hypothalamus development(GO:0021854) |
| 0.1 |
1.1 |
GO:0032781 |
positive regulation of ATPase activity(GO:0032781) |
| 0.1 |
0.2 |
GO:0015712 |
hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.1 |
0.2 |
GO:0045039 |
protein import into mitochondrial inner membrane(GO:0045039) |
| 0.1 |
0.2 |
GO:0021510 |
spinal cord development(GO:0021510) |
| 0.1 |
0.1 |
GO:0042758 |
long-chain fatty acid catabolic process(GO:0042758) |
| 0.1 |
0.1 |
GO:0030167 |
proteoglycan catabolic process(GO:0030167) regulation of endothelial tube morphogenesis(GO:1901509) regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
| 0.1 |
0.4 |
GO:0048484 |
enteric nervous system development(GO:0048484) |
| 0.1 |
0.1 |
GO:0001778 |
plasma membrane repair(GO:0001778) |
| 0.1 |
0.1 |
GO:1902310 |
positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
| 0.1 |
0.6 |
GO:0034643 |
establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
| 0.1 |
1.7 |
GO:0050868 |
negative regulation of T cell activation(GO:0050868) |
| 0.1 |
0.2 |
GO:0070574 |
cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
| 0.1 |
0.2 |
GO:0001510 |
RNA methylation(GO:0001510) |
| 0.1 |
0.2 |
GO:0045204 |
MAPK export from nucleus(GO:0045204) |
| 0.1 |
1.3 |
GO:0030835 |
negative regulation of actin filament depolymerization(GO:0030835) |
| 0.1 |
0.7 |
GO:0008272 |
sulfate transport(GO:0008272) |
| 0.1 |
0.5 |
GO:0018095 |
protein polyglutamylation(GO:0018095) |
| 0.1 |
0.3 |
GO:0048538 |
thymus development(GO:0048538) |
| 0.1 |
0.2 |
GO:0015819 |
lysine transport(GO:0015819) |
| 0.1 |
0.2 |
GO:0090073 |
positive regulation of protein homodimerization activity(GO:0090073) |
| 0.1 |
0.2 |
GO:0035526 |
retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.1 |
0.2 |
GO:0033561 |
regulation of water loss via skin(GO:0033561) establishment of skin barrier(GO:0061436) |
| 0.1 |
0.2 |
GO:0051490 |
negative regulation of filopodium assembly(GO:0051490) |
| 0.1 |
0.2 |
GO:0014904 |
myotube cell development(GO:0014904) |
| 0.1 |
0.4 |
GO:0035871 |
protein K11-linked deubiquitination(GO:0035871) |
| 0.1 |
0.5 |
GO:0006490 |
oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
| 0.1 |
0.5 |
GO:0061470 |
T follicular helper cell differentiation(GO:0061470) |
| 0.0 |
0.4 |
GO:0036037 |
CD8-positive, alpha-beta T cell activation(GO:0036037) CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
| 0.0 |
0.3 |
GO:0090435 |
protein localization to nuclear envelope(GO:0090435) |
| 0.0 |
0.1 |
GO:0035621 |
ER to Golgi ceramide transport(GO:0035621) ceramide transport(GO:0035627) |
| 0.0 |
0.2 |
GO:0048280 |
vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.0 |
1.4 |
GO:0009060 |
aerobic respiration(GO:0009060) |
| 0.0 |
0.1 |
GO:1904262 |
negative regulation of TORC1 signaling(GO:1904262) |
| 0.0 |
0.6 |
GO:0015781 |
nucleotide-sugar transport(GO:0015780) pyrimidine nucleotide-sugar transport(GO:0015781) |
| 0.0 |
1.0 |
GO:0035690 |
cellular response to drug(GO:0035690) |
| 0.0 |
0.6 |
GO:0046855 |
phosphorylated carbohydrate dephosphorylation(GO:0046838) inositol phosphate dephosphorylation(GO:0046855) |
| 0.0 |
0.1 |
GO:0001928 |
regulation of exocyst assembly(GO:0001928) |
| 0.0 |
0.3 |
GO:0090074 |
negative regulation of protein homodimerization activity(GO:0090074) |
| 0.0 |
0.6 |
GO:0006397 |
mRNA processing(GO:0006397) |
| 0.0 |
0.0 |
GO:1901857 |
positive regulation of cellular respiration(GO:1901857) |
| 0.0 |
0.1 |
GO:0003413 |
chondrocyte differentiation involved in endochondral bone morphogenesis(GO:0003413) |
| 0.0 |
0.2 |
GO:0015868 |
purine ribonucleotide transport(GO:0015868) |
| 0.0 |
0.0 |
GO:0098501 |
polynucleotide dephosphorylation(GO:0098501) |
| 0.0 |
0.1 |
GO:0032366 |
intracellular lipid transport(GO:0032365) intracellular sterol transport(GO:0032366) |
| 0.0 |
0.4 |
GO:2000193 |
positive regulation of fatty acid transport(GO:2000193) |
| 0.0 |
0.2 |
GO:0030502 |
negative regulation of bone mineralization(GO:0030502) |
| 0.0 |
0.4 |
GO:0001890 |
placenta development(GO:0001890) |
| 0.0 |
0.2 |
GO:0045852 |
pH elevation(GO:0045852) intracellular pH elevation(GO:0051454) |
| 0.0 |
1.8 |
GO:0070936 |
protein K48-linked ubiquitination(GO:0070936) |
| 0.0 |
0.0 |
GO:0035754 |
B cell chemotaxis(GO:0035754) |
| 0.0 |
0.0 |
GO:0035384 |
thioester biosynthetic process(GO:0035384) acyl-CoA biosynthetic process(GO:0071616) |
| 0.0 |
0.2 |
GO:0042506 |
tyrosine phosphorylation of Stat5 protein(GO:0042506) |
| 0.0 |
0.2 |
GO:0036233 |
glycine import(GO:0036233) |
| 0.0 |
0.1 |
GO:0010826 |
negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
| 0.0 |
0.3 |
GO:2000179 |
positive regulation of neural precursor cell proliferation(GO:2000179) |
| 0.0 |
0.2 |
GO:2001241 |
positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
| 0.0 |
0.1 |
GO:0010890 |
positive regulation of sequestering of triglyceride(GO:0010890) |
| 0.0 |
0.1 |
GO:0001830 |
trophectodermal cell fate commitment(GO:0001830) |
| 0.0 |
0.1 |
GO:0070973 |
protein localization to endoplasmic reticulum exit site(GO:0070973) |
| 0.0 |
0.0 |
GO:0043652 |
engulfment of apoptotic cell(GO:0043652) |
| 0.0 |
0.4 |
GO:0043154 |
negative regulation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0043154) negative regulation of cysteine-type endopeptidase activity(GO:2000117) |
| 0.0 |
0.0 |
GO:0051124 |
synaptic growth at neuromuscular junction(GO:0051124) |
| 0.0 |
0.1 |
GO:0030220 |
platelet formation(GO:0030220) platelet morphogenesis(GO:0036344) |
| 0.0 |
0.3 |
GO:0046835 |
carbohydrate phosphorylation(GO:0046835) |
| 0.0 |
0.2 |
GO:0033210 |
leptin-mediated signaling pathway(GO:0033210) |
| 0.0 |
0.1 |
GO:0050766 |
positive regulation of phagocytosis(GO:0050766) |
| 0.0 |
0.1 |
GO:0016571 |
histone methylation(GO:0016571) |
| 0.0 |
0.1 |
GO:0006370 |
7-methylguanosine mRNA capping(GO:0006370) |
| 0.0 |
0.1 |
GO:0046381 |
CMP-N-acetylneuraminate metabolic process(GO:0046381) |
| 0.0 |
0.3 |
GO:2000045 |
regulation of G1/S transition of mitotic cell cycle(GO:2000045) |
| 0.0 |
0.1 |
GO:0032309 |
icosanoid secretion(GO:0032309) |
| 0.0 |
0.1 |
GO:0018094 |
protein polyglycylation(GO:0018094) |
| 0.0 |
0.1 |
GO:1903232 |
melanosome assembly(GO:1903232) |
| 0.0 |
0.1 |
GO:0031584 |
activation of phospholipase D activity(GO:0031584) |
| 0.0 |
0.1 |
GO:0021957 |
corticospinal tract morphogenesis(GO:0021957) |
| 0.0 |
0.2 |
GO:1904715 |
negative regulation of chaperone-mediated autophagy(GO:1904715) |
| 0.0 |
0.2 |
GO:1902035 |
positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
| 0.0 |
0.0 |
GO:0060390 |
regulation of SMAD protein import into nucleus(GO:0060390) |
| 0.0 |
0.2 |
GO:0030388 |
fructose 1,6-bisphosphate metabolic process(GO:0030388) |
| 0.0 |
0.2 |
GO:0006621 |
protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
| 0.0 |
0.2 |
GO:0044275 |
cellular carbohydrate catabolic process(GO:0044275) |
| 0.0 |
0.1 |
GO:1902528 |
regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
| 0.0 |
0.3 |
GO:0043392 |
negative regulation of DNA binding(GO:0043392) |
| 0.0 |
0.1 |
GO:0051085 |
chaperone mediated protein folding requiring cofactor(GO:0051085) |
| 0.0 |
0.1 |
GO:0010528 |
regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
| 0.0 |
0.2 |
GO:0090305 |
nucleic acid phosphodiester bond hydrolysis(GO:0090305) |
| 0.0 |
1.4 |
GO:0008380 |
RNA splicing(GO:0008380) |
| 0.0 |
0.0 |
GO:1902109 |
negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
| 0.0 |
0.0 |
GO:1900153 |
regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
| 0.0 |
0.8 |
GO:0015985 |
energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
| 0.0 |
0.1 |
GO:0002036 |
regulation of L-glutamate transport(GO:0002036) |
| 0.0 |
0.4 |
GO:0046677 |
response to antibiotic(GO:0046677) |
| 0.0 |
0.0 |
GO:0000305 |
response to oxygen radical(GO:0000305) |
| 0.0 |
0.0 |
GO:0006667 |
sphinganine metabolic process(GO:0006667) |
| 0.0 |
0.1 |
GO:0035106 |
operant conditioning(GO:0035106) |
| 0.0 |
0.3 |
GO:1903078 |
positive regulation of protein localization to plasma membrane(GO:1903078) positive regulation of protein localization to cell periphery(GO:1904377) |
| 0.0 |
0.1 |
GO:2000680 |
regulation of rubidium ion transport(GO:2000680) |
| 0.0 |
0.1 |
GO:0002862 |
negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
| 0.0 |
0.2 |
GO:0032516 |
positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
| 0.0 |
0.8 |
GO:0022900 |
electron transport chain(GO:0022900) |
| 0.0 |
0.1 |
GO:0061635 |
regulation of protein complex stability(GO:0061635) |
| 0.0 |
0.0 |
GO:0051352 |
negative regulation of ligase activity(GO:0051352) negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
| 0.0 |
0.3 |
GO:0002377 |
immunoglobulin production(GO:0002377) |
| 0.0 |
0.1 |
GO:1902042 |
negative regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902042) |
| 0.0 |
0.2 |
GO:0042733 |
embryonic digit morphogenesis(GO:0042733) |
| 0.0 |
0.1 |
GO:1904211 |
membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
| 0.0 |
0.1 |
GO:0070589 |
cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule metabolic process(GO:0044036) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) cell wall organization or biogenesis(GO:0071554) |
| 0.0 |
0.1 |
GO:0021869 |
forebrain ventricular zone progenitor cell division(GO:0021869) |
| 0.0 |
0.1 |
GO:2000210 |
positive regulation of anoikis(GO:2000210) |
| 0.0 |
0.1 |
GO:0016479 |
negative regulation of transcription from RNA polymerase I promoter(GO:0016479) |
| 0.0 |
0.0 |
GO:0006681 |
galactosylceramide metabolic process(GO:0006681) galactolipid metabolic process(GO:0019374) |
| 0.0 |
0.1 |
GO:0001675 |
acrosome assembly(GO:0001675) |
| 0.0 |
0.1 |
GO:2001244 |
positive regulation of intrinsic apoptotic signaling pathway(GO:2001244) |
| 0.0 |
0.1 |
GO:0032926 |
negative regulation of activin receptor signaling pathway(GO:0032926) |
| 0.0 |
0.0 |
GO:0071787 |
endoplasmic reticulum tubular network assembly(GO:0071787) |
| 0.0 |
0.2 |
GO:0032886 |
regulation of microtubule-based process(GO:0032886) |
| 0.0 |
0.1 |
GO:0019509 |
L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
| 0.0 |
0.1 |
GO:0006983 |
ER overload response(GO:0006983) |
| 0.0 |
0.1 |
GO:0010592 |
positive regulation of lamellipodium assembly(GO:0010592) |
| 0.0 |
0.9 |
GO:0030178 |
negative regulation of Wnt signaling pathway(GO:0030178) |
| 0.0 |
0.9 |
GO:0005976 |
polysaccharide metabolic process(GO:0005976) |
| 0.0 |
0.1 |
GO:1904031 |
positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
| 0.0 |
0.3 |
GO:0000413 |
protein peptidyl-prolyl isomerization(GO:0000413) |
| 0.0 |
0.0 |
GO:0006551 |
leucine metabolic process(GO:0006551) |
| 0.0 |
0.3 |
GO:0040015 |
negative regulation of multicellular organism growth(GO:0040015) |
| 0.0 |
0.1 |
GO:0060219 |
camera-type eye photoreceptor cell differentiation(GO:0060219) |
| 0.0 |
0.2 |
GO:0033138 |
positive regulation of peptidyl-serine phosphorylation(GO:0033138) |
| 0.0 |
0.0 |
GO:0051029 |
rRNA transport(GO:0051029) |
| 0.0 |
0.0 |
GO:0006278 |
RNA-dependent DNA biosynthetic process(GO:0006278) telomere maintenance via telomerase(GO:0007004) telomere maintenance via telomere lengthening(GO:0010833) |
| 0.0 |
0.0 |
GO:0046326 |
positive regulation of glucose import(GO:0046326) |
| 0.0 |
0.0 |
GO:1905153 |
regulation of membrane invagination(GO:1905153) |
| 0.0 |
0.1 |
GO:0070050 |
neuron cellular homeostasis(GO:0070050) |
| 0.0 |
0.1 |
GO:0045019 |
negative regulation of nitric oxide biosynthetic process(GO:0045019) negative regulation of nitric oxide metabolic process(GO:1904406) |
| 0.0 |
0.0 |
GO:0090168 |
Golgi reassembly(GO:0090168) |
| 0.0 |
0.0 |
GO:0042135 |
neurotransmitter catabolic process(GO:0042135) |
| 0.0 |
0.1 |
GO:0071897 |
DNA biosynthetic process(GO:0071897) |
| 0.0 |
0.0 |
GO:1903966 |
monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
| 0.0 |
0.1 |
GO:0032528 |
microvillus assembly(GO:0030033) microvillus organization(GO:0032528) |
